Project
PRJNA375882: Comprehensive Mouse Transcriptomic BodyMap
Navigation
Downloads
Results for Klf1
Z-value: 2.67
Motif logo
Transcription factors associated with Klf1
| Gene Symbol | Gene ID | Gene Info |
|---|---|---|
|
Klf1
|
ENSMUSG00000054191.10 | Klf1 |
Activity-expression correlation:
| Gene | Promoter | Pearson corr. coef. | P-value | Plot |
|---|---|---|---|---|
| Klf1 | mm39_v1_chr8_+_85628557_85628621 | -0.12 | 3.3e-01 | Click! |
Activity profile of Klf1 motif
Sorted Z-values of Klf1 motif
Network of associatons between targets according to the STRING database.
First level regulatory network of Klf1
Gene Ontology Analysis
Gene overrepresentation in biological process category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 6.1 | 18.3 | GO:1905000 | regulation of membrane repolarization during atrial cardiac muscle cell action potential(GO:1905000) |
| 4.3 | 12.8 | GO:0010481 | epidermal cell division(GO:0010481) regulation of epidermal cell division(GO:0010482) |
| 3.8 | 11.3 | GO:0060672 | epithelial cell differentiation involved in embryonic placenta development(GO:0060671) epithelial cell morphogenesis involved in placental branching(GO:0060672) |
| 3.7 | 18.6 | GO:0001951 | intestinal D-glucose absorption(GO:0001951) |
| 3.7 | 14.7 | GO:1903575 | cornified envelope assembly(GO:1903575) |
| 3.5 | 10.5 | GO:0060220 | camera-type eye photoreceptor cell fate commitment(GO:0060220) |
| 3.3 | 13.2 | GO:0009608 | response to symbiont(GO:0009608) response to symbiotic bacterium(GO:0009609) |
| 2.6 | 10.6 | GO:2000657 | regulation of apolipoprotein binding(GO:2000656) negative regulation of apolipoprotein binding(GO:2000657) |
| 2.6 | 10.6 | GO:2001137 | positive regulation of endocytic recycling(GO:2001137) |
| 2.6 | 7.7 | GO:2000845 | positive regulation of testosterone secretion(GO:2000845) |
| 2.6 | 15.4 | GO:0032804 | negative regulation of low-density lipoprotein particle receptor catabolic process(GO:0032804) |
| 2.5 | 10.2 | GO:0045415 | negative regulation of interleukin-8 biosynthetic process(GO:0045415) |
| 2.5 | 7.5 | GO:0098974 | postsynaptic actin cytoskeleton organization(GO:0098974) |
| 2.5 | 7.5 | GO:0008292 | acetylcholine biosynthetic process(GO:0008292) acetate ester biosynthetic process(GO:1900620) |
| 2.5 | 7.4 | GO:0035965 | cardiolipin acyl-chain remodeling(GO:0035965) |
| 2.4 | 9.6 | GO:0060598 | dichotomous subdivision of terminal units involved in mammary gland duct morphogenesis(GO:0060598) |
| 2.4 | 7.1 | GO:0090650 | response to oxygen-glucose deprivation(GO:0090649) cellular response to oxygen-glucose deprivation(GO:0090650) |
| 2.3 | 7.0 | GO:0019417 | sulfur oxidation(GO:0019417) |
| 2.2 | 6.7 | GO:0034117 | erythrocyte aggregation(GO:0034117) regulation of erythrocyte aggregation(GO:0034118) |
| 2.1 | 16.6 | GO:0003350 | pulmonary myocardium development(GO:0003350) |
| 2.1 | 4.1 | GO:0002352 | B cell negative selection(GO:0002352) |
| 2.0 | 5.9 | GO:0002582 | myeloid dendritic cell activation involved in immune response(GO:0002277) positive regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002582) positive regulation of antigen processing and presentation of peptide antigen via MHC class II(GO:0002588) |
| 1.9 | 5.8 | GO:0043311 | positive regulation of eosinophil degranulation(GO:0043311) positive regulation of eosinophil activation(GO:1902568) |
| 1.8 | 5.5 | GO:2000388 | negative regulation of integrin activation(GO:0033624) regulation of matrix metallopeptidase secretion(GO:1904464) matrix metallopeptidase secretion(GO:1990773) positive regulation of ovarian follicle development(GO:2000386) regulation of antral ovarian follicle growth(GO:2000387) positive regulation of antral ovarian follicle growth(GO:2000388) |
| 1.8 | 3.6 | GO:0071655 | macrophage colony-stimulating factor production(GO:0036301) granulocyte colony-stimulating factor production(GO:0071611) regulation of granulocyte colony-stimulating factor production(GO:0071655) regulation of macrophage colony-stimulating factor production(GO:1901256) |
| 1.8 | 7.2 | GO:0051599 | response to hydrostatic pressure(GO:0051599) |
| 1.8 | 12.3 | GO:1904217 | regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904217) positive regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904219) positive regulation of serine C-palmitoyltransferase activity(GO:1904222) |
| 1.7 | 10.5 | GO:1900085 | negative regulation of peptidyl-tyrosine autophosphorylation(GO:1900085) negative regulation of inward rectifier potassium channel activity(GO:1903609) |
| 1.7 | 6.9 | GO:0061146 | Peyer's patch morphogenesis(GO:0061146) |
| 1.6 | 4.9 | GO:1990764 | regulation of myofibroblast contraction(GO:1904328) myofibroblast contraction(GO:1990764) |
| 1.6 | 9.7 | GO:2000304 | positive regulation of sphingolipid biosynthetic process(GO:0090154) positive regulation of ceramide biosynthetic process(GO:2000304) |
| 1.6 | 4.8 | GO:0014878 | response to electrical stimulus involved in regulation of muscle adaptation(GO:0014878) |
| 1.6 | 6.2 | GO:2000230 | negative regulation of pancreatic stellate cell proliferation(GO:2000230) |
| 1.5 | 3.0 | GO:1901642 | purine nucleoside transmembrane transport(GO:0015860) nucleoside transmembrane transport(GO:1901642) |
| 1.5 | 3.0 | GO:0010751 | negative regulation of nitric oxide mediated signal transduction(GO:0010751) |
| 1.5 | 6.0 | GO:0030167 | proteoglycan catabolic process(GO:0030167) |
| 1.5 | 7.4 | GO:0002803 | positive regulation of antimicrobial peptide production(GO:0002225) positive regulation of antibacterial peptide production(GO:0002803) |
| 1.5 | 5.8 | GO:0010360 | negative regulation of anion channel activity(GO:0010360) |
| 1.4 | 4.2 | GO:0010512 | negative regulation of phosphatidylinositol biosynthetic process(GO:0010512) |
| 1.4 | 7.0 | GO:0018125 | peptidyl-cysteine methylation(GO:0018125) |
| 1.4 | 11.1 | GO:0090038 | negative regulation of protein kinase C signaling(GO:0090038) |
| 1.4 | 12.4 | GO:0086073 | bundle of His cell-Purkinje myocyte adhesion involved in cell communication(GO:0086073) |
| 1.4 | 12.4 | GO:0006682 | galactosylceramide biosynthetic process(GO:0006682) galactolipid biosynthetic process(GO:0019375) |
| 1.4 | 4.1 | GO:0051542 | elastin biosynthetic process(GO:0051542) |
| 1.3 | 5.3 | GO:0044407 | biofilm formation(GO:0042710) single-species biofilm formation(GO:0044010) single-species biofilm formation in or on host organism(GO:0044407) membrane disruption in other organism(GO:0051673) regulation of single-species biofilm formation(GO:1900190) negative regulation of single-species biofilm formation(GO:1900191) regulation of single-species biofilm formation in or on host organism(GO:1900228) negative regulation of single-species biofilm formation in or on host organism(GO:1900229) |
| 1.3 | 9.3 | GO:2001205 | negative regulation of osteoclast development(GO:2001205) |
| 1.3 | 6.6 | GO:0051121 | hepoxilin metabolic process(GO:0051121) hepoxilin biosynthetic process(GO:0051122) |
| 1.3 | 7.9 | GO:0050760 | thymidylate synthase biosynthetic process(GO:0050757) regulation of thymidylate synthase biosynthetic process(GO:0050758) negative regulation of thymidylate synthase biosynthetic process(GO:0050760) |
| 1.3 | 4.0 | GO:0002159 | desmosome assembly(GO:0002159) |
| 1.3 | 5.1 | GO:1900158 | negative regulation of bone mineralization involved in bone maturation(GO:1900158) |
| 1.3 | 6.4 | GO:0002901 | mature B cell apoptotic process(GO:0002901) regulation of mature B cell apoptotic process(GO:0002905) negative regulation of mature B cell apoptotic process(GO:0002906) |
| 1.3 | 3.8 | GO:0033082 | regulation of extrathymic T cell differentiation(GO:0033082) |
| 1.3 | 5.0 | GO:0006363 | termination of RNA polymerase I transcription(GO:0006363) |
| 1.2 | 7.4 | GO:0061589 | calcium activated phosphatidylserine scrambling(GO:0061589) |
| 1.2 | 6.1 | GO:0097350 | neutrophil clearance(GO:0097350) |
| 1.2 | 1.2 | GO:1902943 | regulation of voltage-gated chloride channel activity(GO:1902941) positive regulation of voltage-gated chloride channel activity(GO:1902943) |
| 1.2 | 3.6 | GO:0031104 | dendrite regeneration(GO:0031104) |
| 1.2 | 3.6 | GO:0048627 | myoblast development(GO:0048627) |
| 1.1 | 3.4 | GO:0097156 | fasciculation of motor neuron axon(GO:0097156) |
| 1.1 | 4.6 | GO:0070649 | formin-nucleated actin cable assembly(GO:0070649) |
| 1.1 | 3.4 | GO:1904117 | response to vasopressin(GO:1904116) cellular response to vasopressin(GO:1904117) |
| 1.1 | 14.6 | GO:1900084 | regulation of peptidyl-tyrosine autophosphorylation(GO:1900084) |
| 1.1 | 7.7 | GO:0097503 | sialylation(GO:0097503) |
| 1.1 | 8.7 | GO:0043987 | histone H3-S10 phosphorylation(GO:0043987) |
| 1.1 | 7.4 | GO:1904180 | negative regulation of membrane depolarization(GO:1904180) |
| 1.1 | 3.2 | GO:0030208 | dermatan sulfate biosynthetic process(GO:0030208) |
| 1.1 | 4.2 | GO:0039663 | fusion of virus membrane with host plasma membrane(GO:0019064) membrane fusion involved in viral entry into host cell(GO:0039663) multi-organism membrane fusion(GO:0044800) |
| 1.0 | 3.1 | GO:1990705 | cholangiocyte proliferation(GO:1990705) |
| 1.0 | 4.2 | GO:2000984 | regulation of ATP citrate synthase activity(GO:2000983) negative regulation of ATP citrate synthase activity(GO:2000984) |
| 1.0 | 1.0 | GO:0070318 | positive regulation of G0 to G1 transition(GO:0070318) |
| 1.0 | 3.1 | GO:0032532 | regulation of microvillus length(GO:0032532) |
| 1.0 | 4.1 | GO:0035524 | proline transmembrane transport(GO:0035524) |
| 1.0 | 5.2 | GO:0002835 | negative regulation of response to tumor cell(GO:0002835) negative regulation of immune response to tumor cell(GO:0002838) |
| 1.0 | 5.1 | GO:0007207 | adenylate cyclase-inhibiting G-protein coupled acetylcholine receptor signaling pathway(GO:0007197) phospholipase C-activating G-protein coupled acetylcholine receptor signaling pathway(GO:0007207) |
| 1.0 | 3.0 | GO:1903281 | positive regulation of calcium:sodium antiporter activity(GO:1903281) |
| 1.0 | 4.0 | GO:0033088 | negative regulation of immature T cell proliferation in thymus(GO:0033088) |
| 1.0 | 2.0 | GO:0071672 | negative regulation of smooth muscle cell chemotaxis(GO:0071672) |
| 1.0 | 6.9 | GO:0035655 | interleukin-18-mediated signaling pathway(GO:0035655) |
| 1.0 | 3.9 | GO:0003133 | BMP signaling pathway involved in heart induction(GO:0003130) endodermal-mesodermal cell signaling(GO:0003133) endodermal-mesodermal cell signaling involved in heart induction(GO:0003134) |
| 1.0 | 1.9 | GO:0070237 | positive regulation of activation-induced cell death of T cells(GO:0070237) |
| 1.0 | 4.8 | GO:0034224 | cellular response to zinc ion starvation(GO:0034224) |
| 1.0 | 3.9 | GO:2001287 | negative regulation of caveolin-mediated endocytosis(GO:2001287) |
| 1.0 | 1.9 | GO:0032487 | regulation of Rap protein signal transduction(GO:0032487) |
| 1.0 | 1.9 | GO:1901074 | regulation of engulfment of apoptotic cell(GO:1901074) |
| 1.0 | 4.8 | GO:0010760 | negative regulation of macrophage chemotaxis(GO:0010760) |
| 0.9 | 1.9 | GO:2000449 | regulation of CD8-positive, alpha-beta T cell extravasation(GO:2000449) |
| 0.9 | 0.9 | GO:0035993 | deltoid tuberosity development(GO:0035993) |
| 0.9 | 5.7 | GO:0018992 | germ-line sex determination(GO:0018992) |
| 0.9 | 3.7 | GO:0030450 | regulation of complement activation, classical pathway(GO:0030450) |
| 0.9 | 5.6 | GO:0006116 | NADH oxidation(GO:0006116) |
| 0.9 | 2.8 | GO:0045404 | positive regulation of interleukin-4 biosynthetic process(GO:0045404) |
| 0.9 | 2.7 | GO:0072752 | cellular response to rapamycin(GO:0072752) |
| 0.9 | 11.5 | GO:0060056 | mammary gland involution(GO:0060056) |
| 0.9 | 0.9 | GO:0035622 | intrahepatic bile duct development(GO:0035622) |
| 0.9 | 12.3 | GO:0010839 | negative regulation of keratinocyte proliferation(GO:0010839) |
| 0.9 | 3.5 | GO:0035989 | tendon development(GO:0035989) |
| 0.9 | 5.3 | GO:0030043 | actin filament fragmentation(GO:0030043) |
| 0.9 | 2.6 | GO:0097185 | amiloride transport(GO:0015898) cellular response to copper ion starvation(GO:0035874) response to azide(GO:0097184) cellular response to azide(GO:0097185) |
| 0.9 | 12.1 | GO:0071493 | cellular response to UV-B(GO:0071493) |
| 0.9 | 0.9 | GO:0097155 | fasciculation of sensory neuron axon(GO:0097155) |
| 0.9 | 21.4 | GO:0019731 | antibacterial humoral response(GO:0019731) |
| 0.8 | 1.7 | GO:1902174 | positive regulation of keratinocyte apoptotic process(GO:1902174) |
| 0.8 | 5.0 | GO:0034465 | response to carbon monoxide(GO:0034465) eye blink reflex(GO:0060082) |
| 0.8 | 5.8 | GO:1902035 | mast cell proliferation(GO:0070662) regulation of mast cell proliferation(GO:0070666) positive regulation of mast cell proliferation(GO:0070668) positive regulation of hematopoietic stem cell proliferation(GO:1902035) |
| 0.8 | 1.6 | GO:0060809 | mesodermal to mesenchymal transition involved in gastrulation(GO:0060809) |
| 0.8 | 2.5 | GO:1901740 | negative regulation of myoblast fusion(GO:1901740) |
| 0.8 | 4.8 | GO:0050916 | sensory perception of sweet taste(GO:0050916) sensory perception of umami taste(GO:0050917) |
| 0.8 | 11.9 | GO:0033623 | regulation of integrin activation(GO:0033623) |
| 0.8 | 9.5 | GO:0035878 | nail development(GO:0035878) |
| 0.8 | 7.8 | GO:0019661 | glucose catabolic process to lactate(GO:0019659) glycolytic fermentation(GO:0019660) glucose catabolic process to lactate via pyruvate(GO:0019661) |
| 0.8 | 3.9 | GO:1904171 | negative regulation of bleb assembly(GO:1904171) |
| 0.8 | 2.3 | GO:0006550 | isoleucine catabolic process(GO:0006550) |
| 0.7 | 3.0 | GO:0015904 | tetracycline transport(GO:0015904) |
| 0.7 | 5.1 | GO:0032962 | positive regulation of inositol trisphosphate biosynthetic process(GO:0032962) |
| 0.7 | 2.2 | GO:0046724 | oxalic acid secretion(GO:0046724) |
| 0.7 | 14.2 | GO:0006000 | fructose metabolic process(GO:0006000) |
| 0.7 | 6.4 | GO:0019673 | GDP-mannose metabolic process(GO:0019673) |
| 0.7 | 4.9 | GO:0010968 | regulation of microtubule nucleation(GO:0010968) |
| 0.7 | 2.8 | GO:0009051 | pentose-phosphate shunt, oxidative branch(GO:0009051) |
| 0.7 | 2.1 | GO:2000503 | positive regulation of natural killer cell chemotaxis(GO:2000503) |
| 0.7 | 2.8 | GO:1901529 | positive regulation of anion channel activity(GO:1901529) |
| 0.7 | 4.1 | GO:0060355 | positive regulation of cell adhesion molecule production(GO:0060355) |
| 0.7 | 8.9 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
| 0.7 | 6.8 | GO:0030579 | ubiquitin-dependent SMAD protein catabolic process(GO:0030579) |
| 0.7 | 12.3 | GO:0060670 | branching involved in labyrinthine layer morphogenesis(GO:0060670) |
| 0.7 | 1.4 | GO:0048320 | axial mesoderm formation(GO:0048320) |
| 0.7 | 13.6 | GO:0090026 | positive regulation of monocyte chemotaxis(GO:0090026) |
| 0.7 | 1.4 | GO:1903944 | regulation of hepatocyte apoptotic process(GO:1903943) negative regulation of hepatocyte apoptotic process(GO:1903944) |
| 0.7 | 28.2 | GO:0060706 | cell differentiation involved in embryonic placenta development(GO:0060706) |
| 0.7 | 2.0 | GO:0045196 | establishment or maintenance of neuroblast polarity(GO:0045196) establishment of neuroblast polarity(GO:0045200) |
| 0.7 | 3.3 | GO:1903463 | regulation of mitotic cell cycle DNA replication(GO:1903463) |
| 0.7 | 2.6 | GO:1902396 | protein localization to bicellular tight junction(GO:1902396) |
| 0.6 | 13.0 | GO:0061179 | negative regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0061179) |
| 0.6 | 3.9 | GO:0010025 | wax biosynthetic process(GO:0010025) wax metabolic process(GO:0010166) |
| 0.6 | 1.9 | GO:0015881 | creatine transport(GO:0015881) |
| 0.6 | 3.2 | GO:1903378 | positive regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903378) |
| 0.6 | 1.9 | GO:0036269 | swimming behavior(GO:0036269) |
| 0.6 | 7.5 | GO:0072675 | osteoclast fusion(GO:0072675) |
| 0.6 | 23.7 | GO:0051016 | barbed-end actin filament capping(GO:0051016) |
| 0.6 | 5.0 | GO:0006561 | proline biosynthetic process(GO:0006561) |
| 0.6 | 2.5 | GO:1902219 | negative regulation of intrinsic apoptotic signaling pathway in response to osmotic stress(GO:1902219) |
| 0.6 | 3.1 | GO:0042538 | hyperosmotic salinity response(GO:0042538) |
| 0.6 | 2.5 | GO:0030311 | poly-N-acetyllactosamine metabolic process(GO:0030309) poly-N-acetyllactosamine biosynthetic process(GO:0030311) |
| 0.6 | 1.8 | GO:0038086 | VEGF-activated platelet-derived growth factor receptor signaling pathway(GO:0038086) positive regulation of cell proliferation by VEGF-activated platelet derived growth factor receptor signaling pathway(GO:0038091) |
| 0.6 | 1.8 | GO:0021644 | vagus nerve morphogenesis(GO:0021644) |
| 0.6 | 1.2 | GO:1901204 | regulation of adrenergic receptor signaling pathway involved in heart process(GO:1901204) |
| 0.6 | 4.2 | GO:0042270 | protection from natural killer cell mediated cytotoxicity(GO:0042270) |
| 0.6 | 2.4 | GO:1903984 | positive regulation of TRAIL-activated apoptotic signaling pathway(GO:1903984) |
| 0.6 | 2.4 | GO:0014707 | branchiomeric skeletal muscle development(GO:0014707) |
| 0.6 | 11.2 | GO:0031268 | pseudopodium organization(GO:0031268) |
| 0.6 | 2.9 | GO:2000680 | regulation of rubidium ion transport(GO:2000680) |
| 0.6 | 5.9 | GO:0015705 | iodide transport(GO:0015705) |
| 0.6 | 1.2 | GO:1902037 | negative regulation of hematopoietic stem cell differentiation(GO:1902037) |
| 0.6 | 2.9 | GO:0098886 | modification of dendritic spine(GO:0098886) |
| 0.6 | 1.7 | GO:1903778 | protein localization to vacuolar membrane(GO:1903778) |
| 0.6 | 4.0 | GO:0036438 | maintenance of lens transparency(GO:0036438) |
| 0.6 | 0.6 | GO:1901668 | regulation of superoxide dismutase activity(GO:1901668) |
| 0.6 | 2.8 | GO:0014722 | regulation of skeletal muscle contraction by calcium ion signaling(GO:0014722) |
| 0.6 | 2.2 | GO:1904158 | axonemal central apparatus assembly(GO:1904158) |
| 0.6 | 4.4 | GO:2000483 | negative regulation of interleukin-8 secretion(GO:2000483) |
| 0.5 | 0.5 | GO:2000137 | negative regulation of cell proliferation involved in heart morphogenesis(GO:2000137) |
| 0.5 | 2.2 | GO:0051866 | general adaptation syndrome(GO:0051866) |
| 0.5 | 7.1 | GO:0016554 | cytidine to uridine editing(GO:0016554) |
| 0.5 | 1.6 | GO:0043973 | histone H3-K4 acetylation(GO:0043973) |
| 0.5 | 1.6 | GO:0070495 | regulation of thrombin receptor signaling pathway(GO:0070494) negative regulation of thrombin receptor signaling pathway(GO:0070495) |
| 0.5 | 8.1 | GO:0090336 | positive regulation of brown fat cell differentiation(GO:0090336) |
| 0.5 | 1.6 | GO:0030046 | parallel actin filament bundle assembly(GO:0030046) |
| 0.5 | 2.7 | GO:0035617 | stress granule disassembly(GO:0035617) |
| 0.5 | 1.1 | GO:0046098 | guanine metabolic process(GO:0046098) |
| 0.5 | 1.6 | GO:0006667 | sphinganine metabolic process(GO:0006667) |
| 0.5 | 4.1 | GO:0002432 | granuloma formation(GO:0002432) |
| 0.5 | 0.5 | GO:1901082 | regulation of relaxation of smooth muscle(GO:1901080) positive regulation of relaxation of smooth muscle(GO:1901082) |
| 0.5 | 1.0 | GO:0046985 | positive regulation of hemoglobin biosynthetic process(GO:0046985) |
| 0.5 | 23.2 | GO:0030834 | regulation of actin filament depolymerization(GO:0030834) |
| 0.5 | 2.5 | GO:0046341 | CDP-diacylglycerol metabolic process(GO:0046341) |
| 0.5 | 2.5 | GO:0019065 | receptor-mediated endocytosis of virus by host cell(GO:0019065) endocytosis involved in viral entry into host cell(GO:0075509) |
| 0.5 | 5.5 | GO:0051971 | positive regulation of transmission of nerve impulse(GO:0051971) |
| 0.5 | 3.5 | GO:0045657 | positive regulation of monocyte differentiation(GO:0045657) |
| 0.5 | 1.5 | GO:0042694 | muscle cell fate specification(GO:0042694) |
| 0.5 | 1.0 | GO:0016332 | establishment or maintenance of polarity of embryonic epithelium(GO:0016332) |
| 0.5 | 1.5 | GO:1904499 | regulation of chromatin-mediated maintenance of transcription(GO:1904499) positive regulation of chromatin-mediated maintenance of transcription(GO:1904501) regulation of euchromatin binding(GO:1904793) |
| 0.5 | 2.4 | GO:0036151 | phosphatidylcholine acyl-chain remodeling(GO:0036151) |
| 0.5 | 2.0 | GO:0006168 | adenine salvage(GO:0006168) adenine metabolic process(GO:0046083) adenine biosynthetic process(GO:0046084) |
| 0.5 | 1.9 | GO:0002337 | B-1a B cell differentiation(GO:0002337) |
| 0.5 | 6.7 | GO:0071361 | cellular response to ethanol(GO:0071361) |
| 0.5 | 1.9 | GO:0006436 | tryptophanyl-tRNA aminoacylation(GO:0006436) |
| 0.5 | 6.1 | GO:0042135 | neurotransmitter catabolic process(GO:0042135) |
| 0.5 | 0.9 | GO:1901382 | chorionic trophoblast cell proliferation(GO:0097360) regulation of chorionic trophoblast cell proliferation(GO:1901382) |
| 0.5 | 7.5 | GO:0042048 | olfactory behavior(GO:0042048) |
| 0.5 | 1.9 | GO:0003017 | lymph circulation(GO:0003017) |
| 0.5 | 1.9 | GO:0015910 | peroxisomal long-chain fatty acid import(GO:0015910) |
| 0.5 | 6.9 | GO:2001197 | regulation of basement membrane assembly involved in embryonic body morphogenesis(GO:1904259) positive regulation of basement membrane assembly involved in embryonic body morphogenesis(GO:1904261) basement membrane assembly involved in embryonic body morphogenesis(GO:2001197) |
| 0.5 | 4.1 | GO:0032463 | negative regulation of protein homooligomerization(GO:0032463) |
| 0.4 | 8.5 | GO:0035428 | hexose transmembrane transport(GO:0035428) |
| 0.4 | 2.2 | GO:0001830 | trophectodermal cell fate commitment(GO:0001830) |
| 0.4 | 12.5 | GO:0097435 | fibril organization(GO:0097435) |
| 0.4 | 2.2 | GO:0046946 | hydroxylysine metabolic process(GO:0046946) hydroxylysine biosynthetic process(GO:0046947) |
| 0.4 | 3.5 | GO:0045654 | positive regulation of megakaryocyte differentiation(GO:0045654) |
| 0.4 | 3.5 | GO:0003433 | chondrocyte development involved in endochondral bone morphogenesis(GO:0003433) |
| 0.4 | 0.9 | GO:0009312 | oligosaccharide biosynthetic process(GO:0009312) |
| 0.4 | 1.7 | GO:0035672 | oligopeptide transmembrane transport(GO:0035672) xenobiotic transport(GO:0042908) |
| 0.4 | 8.1 | GO:2000675 | negative regulation of type B pancreatic cell apoptotic process(GO:2000675) |
| 0.4 | 1.7 | GO:0030951 | establishment or maintenance of microtubule cytoskeleton polarity(GO:0030951) |
| 0.4 | 1.3 | GO:2001226 | negative regulation of chloride transport(GO:2001226) |
| 0.4 | 8.0 | GO:0015693 | magnesium ion transport(GO:0015693) |
| 0.4 | 2.9 | GO:0009405 | pathogenesis(GO:0009405) |
| 0.4 | 1.3 | GO:0001812 | positive regulation of type I hypersensitivity(GO:0001812) |
| 0.4 | 1.2 | GO:0030472 | mitotic spindle organization in nucleus(GO:0030472) |
| 0.4 | 0.8 | GO:2000564 | CD8-positive, alpha-beta T cell proliferation(GO:0035740) regulation of CD8-positive, alpha-beta T cell proliferation(GO:2000564) |
| 0.4 | 5.3 | GO:0046541 | saliva secretion(GO:0046541) |
| 0.4 | 10.6 | GO:0035634 | response to stilbenoid(GO:0035634) |
| 0.4 | 8.1 | GO:0043306 | positive regulation of mast cell activation involved in immune response(GO:0033008) positive regulation of mast cell degranulation(GO:0043306) |
| 0.4 | 2.4 | GO:0021637 | trigeminal nerve morphogenesis(GO:0021636) trigeminal nerve structural organization(GO:0021637) semaphorin-plexin signaling pathway involved in axon guidance(GO:1902287) |
| 0.4 | 2.4 | GO:0000738 | DNA catabolic process, exonucleolytic(GO:0000738) |
| 0.4 | 1.6 | GO:0060743 | epithelial cell maturation involved in prostate gland development(GO:0060743) |
| 0.4 | 2.0 | GO:1904694 | negative regulation of vascular smooth muscle contraction(GO:1904694) |
| 0.4 | 1.2 | GO:0006808 | regulation of nitrogen utilization(GO:0006808) nitrogen utilization(GO:0019740) |
| 0.4 | 1.6 | GO:0060265 | positive regulation of respiratory burst involved in inflammatory response(GO:0060265) |
| 0.4 | 0.8 | GO:0034443 | negative regulation of lipoprotein oxidation(GO:0034443) regulation of smooth muscle cell-matrix adhesion(GO:2000097) |
| 0.4 | 1.9 | GO:0015788 | UDP-N-acetylglucosamine transport(GO:0015788) |
| 0.4 | 2.3 | GO:0003100 | regulation of systemic arterial blood pressure by endothelin(GO:0003100) vein smooth muscle contraction(GO:0014826) |
| 0.4 | 2.3 | GO:0015871 | choline transport(GO:0015871) |
| 0.4 | 2.3 | GO:0015867 | ATP transport(GO:0015867) |
| 0.4 | 1.1 | GO:2000642 | negative regulation of early endosome to late endosome transport(GO:2000642) |
| 0.4 | 10.3 | GO:0060445 | branching involved in salivary gland morphogenesis(GO:0060445) |
| 0.4 | 5.7 | GO:1900029 | positive regulation of ruffle assembly(GO:1900029) |
| 0.4 | 1.9 | GO:0000733 | DNA strand renaturation(GO:0000733) |
| 0.4 | 1.1 | GO:0098749 | cerebellar neuron development(GO:0098749) |
| 0.4 | 1.9 | GO:0010796 | regulation of multivesicular body size(GO:0010796) |
| 0.4 | 8.2 | GO:0060575 | intestinal epithelial cell differentiation(GO:0060575) |
| 0.4 | 3.0 | GO:0009644 | response to high light intensity(GO:0009644) |
| 0.4 | 2.6 | GO:0002636 | positive regulation of germinal center formation(GO:0002636) B cell costimulation(GO:0031296) |
| 0.4 | 2.6 | GO:0045218 | zonula adherens maintenance(GO:0045218) |
| 0.4 | 11.4 | GO:0070208 | protein heterotrimerization(GO:0070208) |
| 0.4 | 3.7 | GO:0010579 | regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway(GO:0010578) positive regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway(GO:0010579) |
| 0.4 | 2.2 | GO:0043415 | positive regulation of skeletal muscle tissue regeneration(GO:0043415) |
| 0.4 | 11.6 | GO:0071470 | cellular response to osmotic stress(GO:0071470) |
| 0.4 | 1.4 | GO:2000546 | positive regulation of cell chemotaxis to fibroblast growth factor(GO:1904849) positive regulation of endothelial cell chemotaxis to fibroblast growth factor(GO:2000546) |
| 0.4 | 1.1 | GO:0061763 | multivesicular body-lysosome fusion(GO:0061763) |
| 0.4 | 0.7 | GO:0048003 | antigen processing and presentation of lipid antigen via MHC class Ib(GO:0048003) antigen processing and presentation, exogenous lipid antigen via MHC class Ib(GO:0048007) |
| 0.4 | 1.1 | GO:0042045 | epithelial fluid transport(GO:0042045) |
| 0.3 | 2.4 | GO:0048069 | eye pigmentation(GO:0048069) |
| 0.3 | 5.6 | GO:0006488 | dolichol-linked oligosaccharide biosynthetic process(GO:0006488) |
| 0.3 | 1.7 | GO:0021615 | glossopharyngeal nerve morphogenesis(GO:0021615) |
| 0.3 | 7.2 | GO:0046855 | inositol phosphate dephosphorylation(GO:0046855) |
| 0.3 | 1.4 | GO:1905150 | regulation of voltage-gated sodium channel activity(GO:1905150) |
| 0.3 | 8.9 | GO:0006308 | DNA catabolic process(GO:0006308) |
| 0.3 | 3.1 | GO:0007213 | G-protein coupled acetylcholine receptor signaling pathway(GO:0007213) |
| 0.3 | 2.1 | GO:1901842 | negative regulation of high voltage-gated calcium channel activity(GO:1901842) |
| 0.3 | 10.6 | GO:0034260 | negative regulation of GTPase activity(GO:0034260) |
| 0.3 | 4.8 | GO:0035372 | protein localization to microtubule(GO:0035372) |
| 0.3 | 3.4 | GO:0032808 | lacrimal gland development(GO:0032808) |
| 0.3 | 2.0 | GO:0061045 | negative regulation of wound healing(GO:0061045) |
| 0.3 | 1.7 | GO:1902340 | telomeric heterochromatin assembly(GO:0031509) negative regulation of chromosome condensation(GO:1902340) |
| 0.3 | 2.7 | GO:0048227 | plasma membrane to endosome transport(GO:0048227) |
| 0.3 | 0.7 | GO:0031959 | mineralocorticoid receptor signaling pathway(GO:0031959) |
| 0.3 | 3.0 | GO:0035726 | common myeloid progenitor cell proliferation(GO:0035726) |
| 0.3 | 2.0 | GO:0072592 | oxygen metabolic process(GO:0072592) |
| 0.3 | 2.3 | GO:1990034 | calcium ion export from cell(GO:1990034) |
| 0.3 | 4.0 | GO:0035879 | lactate transport(GO:0015727) lactate transmembrane transport(GO:0035873) plasma membrane lactate transport(GO:0035879) |
| 0.3 | 1.3 | GO:0006069 | ethanol oxidation(GO:0006069) |
| 0.3 | 18.9 | GO:0045103 | intermediate filament-based process(GO:0045103) |
| 0.3 | 1.3 | GO:0060279 | positive regulation of ovulation(GO:0060279) |
| 0.3 | 2.6 | GO:2000609 | regulation of thyroid hormone generation(GO:2000609) |
| 0.3 | 1.0 | GO:1903632 | regulation of aminoacyl-tRNA ligase activity(GO:1903630) positive regulation of aminoacyl-tRNA ligase activity(GO:1903632) |
| 0.3 | 5.3 | GO:2001275 | positive regulation of glucose import in response to insulin stimulus(GO:2001275) |
| 0.3 | 1.9 | GO:0045905 | translational frameshifting(GO:0006452) positive regulation of translational termination(GO:0045905) |
| 0.3 | 0.9 | GO:1903406 | regulation of sodium:potassium-exchanging ATPase activity(GO:1903406) |
| 0.3 | 3.1 | GO:0007021 | tubulin complex assembly(GO:0007021) |
| 0.3 | 13.2 | GO:0003009 | skeletal muscle contraction(GO:0003009) |
| 0.3 | 0.9 | GO:0090403 | oxidative stress-induced premature senescence(GO:0090403) |
| 0.3 | 0.9 | GO:0070459 | prolactin secretion(GO:0070459) |
| 0.3 | 0.6 | GO:0014805 | smooth muscle adaptation(GO:0014805) |
| 0.3 | 0.9 | GO:0002017 | regulation of blood volume by renal aldosterone(GO:0002017) |
| 0.3 | 4.4 | GO:0030644 | cellular chloride ion homeostasis(GO:0030644) |
| 0.3 | 2.4 | GO:0016198 | axon choice point recognition(GO:0016198) |
| 0.3 | 19.1 | GO:1902476 | chloride transmembrane transport(GO:1902476) |
| 0.3 | 1.4 | GO:0032290 | peripheral nervous system myelin formation(GO:0032290) |
| 0.3 | 2.0 | GO:0007527 | adult somatic muscle development(GO:0007527) |
| 0.3 | 1.4 | GO:0038032 | termination of G-protein coupled receptor signaling pathway(GO:0038032) |
| 0.3 | 4.3 | GO:1900027 | regulation of ruffle assembly(GO:1900027) |
| 0.3 | 1.7 | GO:0032511 | late endosome to vacuole transport via multivesicular body sorting pathway(GO:0032511) |
| 0.3 | 24.2 | GO:0046785 | microtubule polymerization(GO:0046785) |
| 0.3 | 1.1 | GO:0060988 | lipid tube assembly(GO:0060988) |
| 0.3 | 2.6 | GO:0060120 | auditory receptor cell fate commitment(GO:0009912) inner ear receptor cell fate commitment(GO:0060120) |
| 0.3 | 0.8 | GO:0034164 | negative regulation of toll-like receptor 9 signaling pathway(GO:0034164) |
| 0.3 | 1.1 | GO:0061043 | positive regulation of vascular wound healing(GO:0035470) positive regulation of mast cell chemotaxis(GO:0060754) regulation of vascular wound healing(GO:0061043) |
| 0.3 | 1.7 | GO:0001878 | response to yeast(GO:0001878) |
| 0.3 | 2.2 | GO:0033631 | cell-cell adhesion mediated by integrin(GO:0033631) |
| 0.3 | 1.7 | GO:0042636 | negative regulation of hair cycle(GO:0042636) |
| 0.3 | 0.8 | GO:0098735 | positive regulation of the force of heart contraction(GO:0098735) |
| 0.3 | 0.8 | GO:2000016 | negative regulation of determination of dorsal identity(GO:2000016) |
| 0.3 | 0.3 | GO:1903969 | regulation of macrophage colony-stimulating factor signaling pathway(GO:1902226) regulation of response to macrophage colony-stimulating factor(GO:1903969) regulation of cellular response to macrophage colony-stimulating factor stimulus(GO:1903972) |
| 0.3 | 1.1 | GO:0010991 | negative regulation of SMAD protein complex assembly(GO:0010991) |
| 0.3 | 2.4 | GO:0035810 | positive regulation of urine volume(GO:0035810) |
| 0.3 | 1.9 | GO:0061436 | establishment of skin barrier(GO:0061436) |
| 0.3 | 0.8 | GO:1903028 | regulation of opsonization(GO:1903027) positive regulation of opsonization(GO:1903028) |
| 0.3 | 2.4 | GO:0033353 | S-adenosylmethionine cycle(GO:0033353) |
| 0.3 | 2.1 | GO:0007144 | female meiosis I(GO:0007144) |
| 0.3 | 0.8 | GO:0030327 | prenylated protein catabolic process(GO:0030327) |
| 0.3 | 3.1 | GO:0014807 | regulation of somitogenesis(GO:0014807) |
| 0.3 | 1.0 | GO:0051562 | negative regulation of mitochondrial calcium ion concentration(GO:0051562) |
| 0.3 | 2.5 | GO:0061302 | smooth muscle cell-matrix adhesion(GO:0061302) |
| 0.3 | 1.5 | GO:1902969 | mitotic DNA replication(GO:1902969) |
| 0.3 | 1.3 | GO:0044351 | macropinocytosis(GO:0044351) |
| 0.3 | 1.8 | GO:0019372 | lipoxygenase pathway(GO:0019372) |
| 0.3 | 1.8 | GO:0070327 | thyroid hormone transport(GO:0070327) |
| 0.3 | 1.5 | GO:1903182 | regulation of SUMO transferase activity(GO:1903182) positive regulation of SUMO transferase activity(GO:1903755) |
| 0.2 | 3.7 | GO:0016576 | histone dephosphorylation(GO:0016576) |
| 0.2 | 0.5 | GO:1903978 | regulation of microglial cell activation(GO:1903978) |
| 0.2 | 16.8 | GO:0038083 | peptidyl-tyrosine autophosphorylation(GO:0038083) |
| 0.2 | 0.2 | GO:0060994 | regulation of transcription from RNA polymerase II promoter involved in kidney development(GO:0060994) |
| 0.2 | 1.9 | GO:0006002 | fructose 6-phosphate metabolic process(GO:0006002) |
| 0.2 | 1.0 | GO:0006669 | sphinganine-1-phosphate biosynthetic process(GO:0006669) |
| 0.2 | 0.7 | GO:0043385 | mycotoxin metabolic process(GO:0043385) aflatoxin metabolic process(GO:0046222) organic heteropentacyclic compound metabolic process(GO:1901376) |
| 0.2 | 1.0 | GO:0007217 | tachykinin receptor signaling pathway(GO:0007217) |
| 0.2 | 1.2 | GO:2000562 | CD4-positive, alpha-beta T cell proliferation(GO:0035739) regulation of CD4-positive, alpha-beta T cell proliferation(GO:2000561) negative regulation of CD4-positive, alpha-beta T cell proliferation(GO:2000562) |
| 0.2 | 0.9 | GO:1902683 | regulation of receptor localization to synapse(GO:1902683) |
| 0.2 | 4.7 | GO:0071236 | cellular response to antibiotic(GO:0071236) |
| 0.2 | 1.4 | GO:0010637 | negative regulation of mitochondrial fusion(GO:0010637) |
| 0.2 | 4.9 | GO:0040015 | negative regulation of multicellular organism growth(GO:0040015) |
| 0.2 | 1.1 | GO:0050902 | leukocyte adhesive activation(GO:0050902) |
| 0.2 | 0.2 | GO:0010847 | regulation of chromatin assembly(GO:0010847) |
| 0.2 | 0.2 | GO:2000111 | positive regulation of macrophage apoptotic process(GO:2000111) regulation of thyroid-stimulating hormone secretion(GO:2000612) |
| 0.2 | 11.6 | GO:0006506 | GPI anchor biosynthetic process(GO:0006506) |
| 0.2 | 1.4 | GO:2000427 | positive regulation of apoptotic cell clearance(GO:2000427) |
| 0.2 | 1.6 | GO:0046826 | negative regulation of protein export from nucleus(GO:0046826) |
| 0.2 | 0.9 | GO:0010286 | heat acclimation(GO:0010286) |
| 0.2 | 2.7 | GO:0001778 | plasma membrane repair(GO:0001778) |
| 0.2 | 4.2 | GO:0043552 | positive regulation of phosphatidylinositol 3-kinase activity(GO:0043552) |
| 0.2 | 2.2 | GO:0035507 | regulation of myosin-light-chain-phosphatase activity(GO:0035507) |
| 0.2 | 6.2 | GO:0043616 | keratinocyte proliferation(GO:0043616) |
| 0.2 | 1.5 | GO:0031580 | membrane raft polarization(GO:0001766) membrane raft distribution(GO:0031580) |
| 0.2 | 1.5 | GO:0010288 | response to lead ion(GO:0010288) |
| 0.2 | 1.7 | GO:0060316 | positive regulation of ryanodine-sensitive calcium-release channel activity(GO:0060316) |
| 0.2 | 2.3 | GO:0071294 | cellular response to zinc ion(GO:0071294) |
| 0.2 | 1.1 | GO:0060676 | ureteric bud formation(GO:0060676) |
| 0.2 | 0.6 | GO:2001245 | regulation of phosphatidylcholine biosynthetic process(GO:2001245) |
| 0.2 | 2.1 | GO:1990440 | positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress(GO:1990440) |
| 0.2 | 3.0 | GO:0051764 | actin crosslink formation(GO:0051764) |
| 0.2 | 1.0 | GO:0035728 | response to hepatocyte growth factor(GO:0035728) |
| 0.2 | 2.5 | GO:2000254 | regulation of male germ cell proliferation(GO:2000254) |
| 0.2 | 1.2 | GO:0060158 | phospholipase C-activating dopamine receptor signaling pathway(GO:0060158) |
| 0.2 | 0.4 | GO:0031117 | positive regulation of microtubule depolymerization(GO:0031117) |
| 0.2 | 0.6 | GO:0070973 | protein localization to endoplasmic reticulum exit site(GO:0070973) |
| 0.2 | 0.6 | GO:0045083 | negative regulation of interleukin-12 biosynthetic process(GO:0045083) response to diterpene(GO:1904629) cellular response to diterpene(GO:1904630) response to glucoside(GO:1904631) cellular response to glucoside(GO:1904632) |
| 0.2 | 0.6 | GO:0061762 | CAMKK-AMPK signaling cascade(GO:0061762) |
| 0.2 | 1.6 | GO:0006102 | isocitrate metabolic process(GO:0006102) |
| 0.2 | 1.0 | GO:0070829 | heterochromatin maintenance(GO:0070829) |
| 0.2 | 1.4 | GO:0033210 | leptin-mediated signaling pathway(GO:0033210) |
| 0.2 | 2.4 | GO:0010713 | negative regulation of collagen metabolic process(GO:0010713) negative regulation of collagen biosynthetic process(GO:0032966) |
| 0.2 | 6.4 | GO:0031424 | keratinization(GO:0031424) |
| 0.2 | 2.0 | GO:0010032 | meiotic chromosome condensation(GO:0010032) |
| 0.2 | 0.6 | GO:0019626 | short-chain fatty acid catabolic process(GO:0019626) |
| 0.2 | 2.0 | GO:0048266 | behavioral response to pain(GO:0048266) |
| 0.2 | 0.6 | GO:0034141 | positive regulation of toll-like receptor 3 signaling pathway(GO:0034141) |
| 0.2 | 1.4 | GO:0038089 | positive regulation of cell migration by vascular endothelial growth factor signaling pathway(GO:0038089) |
| 0.2 | 3.9 | GO:0032292 | myelination in peripheral nervous system(GO:0022011) peripheral nervous system axon ensheathment(GO:0032292) |
| 0.2 | 0.6 | GO:0070316 | G0 to G1 transition(GO:0045023) regulation of G0 to G1 transition(GO:0070316) negative regulation of G0 to G1 transition(GO:0070317) |
| 0.2 | 1.7 | GO:0018344 | protein geranylgeranylation(GO:0018344) |
| 0.2 | 1.0 | GO:0042256 | mature ribosome assembly(GO:0042256) |
| 0.2 | 5.6 | GO:0060512 | prostate gland morphogenesis(GO:0060512) |
| 0.2 | 2.3 | GO:0033234 | negative regulation of protein sumoylation(GO:0033234) |
| 0.2 | 1.1 | GO:1990839 | response to endothelin(GO:1990839) |
| 0.2 | 1.7 | GO:0060501 | positive regulation of epithelial cell proliferation involved in lung morphogenesis(GO:0060501) |
| 0.2 | 2.0 | GO:1903207 | neuron death in response to hydrogen peroxide(GO:0036476) regulation of hydrogen peroxide-induced neuron death(GO:1903207) negative regulation of hydrogen peroxide-induced neuron death(GO:1903208) |
| 0.2 | 0.6 | GO:1901165 | positive regulation of trophoblast cell migration(GO:1901165) |
| 0.2 | 0.7 | GO:2001015 | negative regulation of skeletal muscle cell differentiation(GO:2001015) |
| 0.2 | 2.0 | GO:0035898 | parathyroid hormone secretion(GO:0035898) |
| 0.2 | 10.9 | GO:0070527 | platelet aggregation(GO:0070527) |
| 0.2 | 0.5 | GO:0072488 | ammonium transmembrane transport(GO:0072488) |
| 0.2 | 2.0 | GO:0032272 | negative regulation of protein polymerization(GO:0032272) |
| 0.2 | 2.9 | GO:0043312 | neutrophil degranulation(GO:0043312) |
| 0.2 | 5.5 | GO:0051482 | positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G-protein coupled signaling pathway(GO:0051482) |
| 0.2 | 0.5 | GO:0031284 | positive regulation of guanylate cyclase activity(GO:0031284) |
| 0.2 | 1.1 | GO:0033326 | cerebrospinal fluid secretion(GO:0033326) |
| 0.2 | 3.1 | GO:0061577 | calcium ion transmembrane transport via high voltage-gated calcium channel(GO:0061577) |
| 0.2 | 0.9 | GO:0099590 | neurotransmitter receptor internalization(GO:0099590) |
| 0.2 | 0.7 | GO:0030916 | otic vesicle formation(GO:0030916) |
| 0.2 | 0.7 | GO:0060155 | platelet dense granule organization(GO:0060155) |
| 0.2 | 3.2 | GO:0000920 | cell separation after cytokinesis(GO:0000920) |
| 0.2 | 0.3 | GO:0002339 | B cell selection(GO:0002339) peripheral B cell selection(GO:0002343) B cell affinity maturation(GO:0002344) |
| 0.2 | 4.4 | GO:0000028 | ribosomal small subunit assembly(GO:0000028) |
| 0.2 | 0.3 | GO:0005984 | disaccharide metabolic process(GO:0005984) |
| 0.2 | 1.5 | GO:0090232 | positive regulation of spindle checkpoint(GO:0090232) positive regulation of mitotic cell cycle spindle assembly checkpoint(GO:0090267) |
| 0.2 | 1.0 | GO:2000327 | regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000325) positive regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000327) |
| 0.2 | 0.8 | GO:0045348 | positive regulation of MHC class II biosynthetic process(GO:0045348) |
| 0.2 | 19.7 | GO:0007596 | blood coagulation(GO:0007596) |
| 0.2 | 2.0 | GO:0031954 | positive regulation of protein autophosphorylation(GO:0031954) |
| 0.2 | 2.6 | GO:0002523 | leukocyte migration involved in inflammatory response(GO:0002523) |
| 0.2 | 1.1 | GO:0042373 | vitamin K metabolic process(GO:0042373) |
| 0.2 | 0.3 | GO:0036509 | trimming of terminal mannose on B branch(GO:0036509) endoplasmic reticulum mannose trimming(GO:1904380) |
| 0.2 | 0.5 | GO:0007182 | common-partner SMAD protein phosphorylation(GO:0007182) |
| 0.2 | 5.0 | GO:0007212 | dopamine receptor signaling pathway(GO:0007212) |
| 0.2 | 1.6 | GO:0036444 | calcium ion transmembrane import into mitochondrion(GO:0036444) |
| 0.2 | 1.0 | GO:0019276 | UDP-N-acetylgalactosamine metabolic process(GO:0019276) |
| 0.2 | 1.9 | GO:0045953 | negative regulation of natural killer cell mediated cytotoxicity(GO:0045953) |
| 0.2 | 0.8 | GO:0002536 | respiratory burst involved in inflammatory response(GO:0002536) |
| 0.2 | 2.7 | GO:0097062 | dendritic spine maintenance(GO:0097062) |
| 0.2 | 1.3 | GO:0097428 | protein maturation by iron-sulfur cluster transfer(GO:0097428) |
| 0.2 | 0.8 | GO:0002606 | regulation of dendritic cell antigen processing and presentation(GO:0002604) positive regulation of dendritic cell antigen processing and presentation(GO:0002606) |
| 0.2 | 1.6 | GO:2000672 | negative regulation of motor neuron apoptotic process(GO:2000672) |
| 0.2 | 0.9 | GO:2000484 | positive regulation of interleukin-8 secretion(GO:2000484) |
| 0.2 | 0.5 | GO:0002541 | activation of plasma proteins involved in acute inflammatory response(GO:0002541) |
| 0.2 | 1.6 | GO:0035970 | peptidyl-threonine dephosphorylation(GO:0035970) |
| 0.2 | 0.5 | GO:1990428 | miRNA transport(GO:1990428) |
| 0.2 | 3.3 | GO:1901897 | regulation of relaxation of cardiac muscle(GO:1901897) |
| 0.2 | 7.3 | GO:0010972 | negative regulation of G2/M transition of mitotic cell cycle(GO:0010972) |
| 0.2 | 2.9 | GO:0032464 | positive regulation of protein homooligomerization(GO:0032464) |
| 0.2 | 1.2 | GO:0000185 | activation of MAPKKK activity(GO:0000185) |
| 0.2 | 2.0 | GO:0051642 | centrosome localization(GO:0051642) |
| 0.2 | 0.3 | GO:0016240 | autophagosome docking(GO:0016240) |
| 0.2 | 0.3 | GO:0034971 | histone H3-R17 methylation(GO:0034971) |
| 0.2 | 0.5 | GO:0021764 | amygdala development(GO:0021764) |
| 0.1 | 1.0 | GO:0021815 | cell motility involved in cerebral cortex radial glia guided migration(GO:0021814) modulation of microtubule cytoskeleton involved in cerebral cortex radial glia guided migration(GO:0021815) nucleokinesis involved in cell motility in cerebral cortex radial glia guided migration(GO:0021817) nuclear migration along microtubule(GO:0030473) nuclear matrix organization(GO:0043578) nuclear matrix anchoring at nuclear membrane(GO:0090292) |
| 0.1 | 9.5 | GO:0006821 | chloride transport(GO:0006821) |
| 0.1 | 0.6 | GO:0006344 | maintenance of chromatin silencing(GO:0006344) |
| 0.1 | 0.3 | GO:0031282 | regulation of guanylate cyclase activity(GO:0031282) |
| 0.1 | 1.6 | GO:0048386 | positive regulation of retinoic acid receptor signaling pathway(GO:0048386) |
| 0.1 | 2.0 | GO:0032926 | negative regulation of activin receptor signaling pathway(GO:0032926) |
| 0.1 | 1.6 | GO:0031069 | hair follicle morphogenesis(GO:0031069) |
| 0.1 | 2.4 | GO:0016998 | cell wall macromolecule catabolic process(GO:0016998) cell wall macromolecule metabolic process(GO:0044036) cell wall organization or biogenesis(GO:0071554) |
| 0.1 | 0.3 | GO:2000301 | negative regulation of synaptic vesicle exocytosis(GO:2000301) |
| 0.1 | 1.3 | GO:0070863 | positive regulation of protein exit from endoplasmic reticulum(GO:0070863) |
| 0.1 | 2.8 | GO:2000480 | negative regulation of cAMP-dependent protein kinase activity(GO:2000480) |
| 0.1 | 1.4 | GO:0032530 | regulation of microvillus organization(GO:0032530) |
| 0.1 | 0.6 | GO:0031204 | posttranslational protein targeting to membrane, translocation(GO:0031204) |
| 0.1 | 2.4 | GO:0036010 | protein localization to endosome(GO:0036010) |
| 0.1 | 0.6 | GO:0051612 | negative regulation of neurotransmitter uptake(GO:0051581) negative regulation of serotonin uptake(GO:0051612) |
| 0.1 | 0.7 | GO:0098957 | anterograde axonal transport of mitochondrion(GO:0098957) |
| 0.1 | 1.9 | GO:0060033 | anatomical structure regression(GO:0060033) |
| 0.1 | 0.5 | GO:1903715 | regulation of aerobic respiration(GO:1903715) |
| 0.1 | 0.5 | GO:0045629 | negative regulation of T-helper 2 cell differentiation(GO:0045629) |
| 0.1 | 0.1 | GO:0051036 | regulation of endosome size(GO:0051036) |
| 0.1 | 0.1 | GO:0003415 | chondrocyte hypertrophy(GO:0003415) |
| 0.1 | 2.1 | GO:0035493 | SNARE complex assembly(GO:0035493) |
| 0.1 | 0.7 | GO:0051025 | negative regulation of immunoglobulin secretion(GO:0051025) |
| 0.1 | 1.3 | GO:0021506 | anterior neuropore closure(GO:0021506) neuropore closure(GO:0021995) |
| 0.1 | 0.5 | GO:0071922 | establishment of sister chromatid cohesion(GO:0034085) cohesin loading(GO:0071921) regulation of cohesin loading(GO:0071922) |
| 0.1 | 3.7 | GO:0014911 | positive regulation of smooth muscle cell migration(GO:0014911) |
| 0.1 | 0.1 | GO:0003294 | atrial ventricular junction remodeling(GO:0003294) regulation of cell communication by chemical coupling(GO:0010645) positive regulation of cell communication by chemical coupling(GO:0010652) |
| 0.1 | 1.8 | GO:0006751 | glutathione catabolic process(GO:0006751) |
| 0.1 | 1.0 | GO:0046598 | positive regulation of viral entry into host cell(GO:0046598) |
| 0.1 | 2.7 | GO:0042347 | negative regulation of NF-kappaB import into nucleus(GO:0042347) |
| 0.1 | 1.1 | GO:0035280 | miRNA loading onto RISC involved in gene silencing by miRNA(GO:0035280) |
| 0.1 | 1.0 | GO:1903800 | positive regulation of production of miRNAs involved in gene silencing by miRNA(GO:1903800) |
| 0.1 | 0.5 | GO:0060011 | Sertoli cell proliferation(GO:0060011) |
| 0.1 | 0.8 | GO:0003096 | renal sodium ion transport(GO:0003096) renal sodium ion absorption(GO:0070294) |
| 0.1 | 0.7 | GO:0055075 | potassium ion homeostasis(GO:0055075) |
| 0.1 | 0.7 | GO:0051131 | chaperone-mediated protein complex assembly(GO:0051131) |
| 0.1 | 1.6 | GO:0034453 | microtubule anchoring(GO:0034453) |
| 0.1 | 0.6 | GO:0043615 | astrocyte cell migration(GO:0043615) |
| 0.1 | 0.2 | GO:0002215 | defense response to nematode(GO:0002215) |
| 0.1 | 1.1 | GO:0046208 | spermine catabolic process(GO:0046208) |
| 0.1 | 0.4 | GO:0021785 | branchiomotor neuron axon guidance(GO:0021785) |
| 0.1 | 0.7 | GO:0060178 | regulation of exocyst localization(GO:0060178) |
| 0.1 | 2.1 | GO:1902043 | positive regulation of extrinsic apoptotic signaling pathway via death domain receptors(GO:1902043) |
| 0.1 | 0.9 | GO:0071802 | negative regulation of podosome assembly(GO:0071802) |
| 0.1 | 0.7 | GO:0016338 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules(GO:0016338) |
| 0.1 | 1.3 | GO:2000576 | positive regulation of microtubule motor activity(GO:2000576) |
| 0.1 | 2.5 | GO:0033169 | histone H3-K9 demethylation(GO:0033169) |
| 0.1 | 0.3 | GO:0061193 | taste bud development(GO:0061193) |
| 0.1 | 0.2 | GO:0045448 | regulation of mitotic cell cycle, embryonic(GO:0009794) mitotic cell cycle, embryonic(GO:0045448) |
| 0.1 | 0.6 | GO:0015842 | aminergic neurotransmitter loading into synaptic vesicle(GO:0015842) |
| 0.1 | 1.0 | GO:0043011 | myeloid dendritic cell differentiation(GO:0043011) |
| 0.1 | 0.7 | GO:0034650 | cortisol metabolic process(GO:0034650) cortisol biosynthetic process(GO:0034651) |
| 0.1 | 0.4 | GO:1902269 | positive regulation of polyamine transmembrane transport(GO:1902269) |
| 0.1 | 0.4 | GO:0010701 | positive regulation of norepinephrine secretion(GO:0010701) |
| 0.1 | 0.4 | GO:0098914 | membrane repolarization during atrial cardiac muscle cell action potential(GO:0098914) |
| 0.1 | 0.4 | GO:0060830 | ciliary receptor clustering involved in smoothened signaling pathway(GO:0060830) |
| 0.1 | 1.5 | GO:0007175 | negative regulation of epidermal growth factor-activated receptor activity(GO:0007175) |
| 0.1 | 1.9 | GO:0070935 | 3'-UTR-mediated mRNA stabilization(GO:0070935) |
| 0.1 | 0.9 | GO:0055098 | response to low-density lipoprotein particle(GO:0055098) |
| 0.1 | 1.1 | GO:0046641 | positive regulation of alpha-beta T cell proliferation(GO:0046641) |
| 0.1 | 1.4 | GO:0031937 | positive regulation of chromatin silencing(GO:0031937) |
| 0.1 | 0.4 | GO:0000973 | posttranscriptional tethering of RNA polymerase II gene DNA at nuclear periphery(GO:0000973) |
| 0.1 | 2.7 | GO:0090162 | establishment of epithelial cell polarity(GO:0090162) |
| 0.1 | 0.8 | GO:0044805 | late nucleophagy(GO:0044805) |
| 0.1 | 13.7 | GO:0043588 | skin development(GO:0043588) |
| 0.1 | 1.3 | GO:1902099 | regulation of mitotic metaphase/anaphase transition(GO:0030071) regulation of metaphase/anaphase transition of cell cycle(GO:1902099) |
| 0.1 | 3.2 | GO:0000027 | ribosomal large subunit assembly(GO:0000027) |
| 0.1 | 3.1 | GO:0045746 | negative regulation of Notch signaling pathway(GO:0045746) |
| 0.1 | 1.7 | GO:0051044 | positive regulation of membrane protein ectodomain proteolysis(GO:0051044) |
| 0.1 | 4.7 | GO:0007405 | neuroblast proliferation(GO:0007405) |
| 0.1 | 0.8 | GO:0090050 | positive regulation of cell migration involved in sprouting angiogenesis(GO:0090050) |
| 0.1 | 3.2 | GO:0043267 | negative regulation of potassium ion transport(GO:0043267) |
| 0.1 | 0.4 | GO:0070966 | nuclear-transcribed mRNA catabolic process, no-go decay(GO:0070966) |
| 0.1 | 1.5 | GO:0032211 | negative regulation of telomere maintenance via telomerase(GO:0032211) |
| 0.1 | 0.8 | GO:0048194 | Golgi vesicle budding(GO:0048194) |
| 0.1 | 0.7 | GO:0006868 | glutamine transport(GO:0006868) |
| 0.1 | 0.3 | GO:0090172 | attachment of spindle microtubules to kinetochore involved in homologous chromosome segregation(GO:0051455) microtubule cytoskeleton organization involved in homologous chromosome segregation(GO:0090172) |
| 0.1 | 0.9 | GO:0070131 | positive regulation of mitochondrial translation(GO:0070131) |
| 0.1 | 0.5 | GO:0015676 | nickel cation transport(GO:0015675) vanadium ion transport(GO:0015676) lead ion transport(GO:0015692) |
| 0.1 | 1.0 | GO:0042633 | molting cycle(GO:0042303) hair cycle(GO:0042633) |
| 0.1 | 0.4 | GO:0006742 | NADP catabolic process(GO:0006742) |
| 0.1 | 3.2 | GO:1900026 | positive regulation of substrate adhesion-dependent cell spreading(GO:1900026) |
| 0.1 | 1.3 | GO:0060396 | growth hormone receptor signaling pathway(GO:0060396) cellular response to growth hormone stimulus(GO:0071378) |
| 0.1 | 0.3 | GO:0090204 | protein localization to nuclear pore(GO:0090204) negative regulation of vascular endothelial growth factor production(GO:1904046) |
| 0.1 | 0.8 | GO:0070813 | hydrogen sulfide metabolic process(GO:0070813) |
| 0.1 | 1.2 | GO:0030252 | growth hormone secretion(GO:0030252) |
| 0.1 | 0.5 | GO:0046103 | inosine biosynthetic process(GO:0046103) |
| 0.1 | 0.4 | GO:2001206 | positive regulation of osteoclast development(GO:2001206) |
| 0.1 | 0.6 | GO:0014883 | transition between fast and slow fiber(GO:0014883) |
| 0.1 | 0.3 | GO:0030576 | Cajal body organization(GO:0030576) |
| 0.1 | 0.6 | GO:1901185 | negative regulation of epidermal growth factor receptor signaling pathway(GO:0042059) negative regulation of ERBB signaling pathway(GO:1901185) |
| 0.1 | 0.2 | GO:2000158 | positive regulation of ubiquitin-specific protease activity(GO:2000158) |
| 0.1 | 2.6 | GO:0086010 | membrane depolarization during action potential(GO:0086010) |
| 0.1 | 1.0 | GO:0045742 | positive regulation of epidermal growth factor receptor signaling pathway(GO:0045742) positive regulation of ERBB signaling pathway(GO:1901186) |
| 0.1 | 1.1 | GO:0072673 | lamellipodium morphogenesis(GO:0072673) |
| 0.1 | 0.5 | GO:1902166 | negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator(GO:1902166) |
| 0.1 | 1.9 | GO:0031572 | G2 DNA damage checkpoint(GO:0031572) |
| 0.1 | 0.5 | GO:1902237 | positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway(GO:1902237) |
| 0.1 | 0.9 | GO:0050901 | leukocyte tethering or rolling(GO:0050901) |
| 0.1 | 0.7 | GO:0097012 | cellular response to granulocyte macrophage colony-stimulating factor stimulus(GO:0097011) response to granulocyte macrophage colony-stimulating factor(GO:0097012) |
| 0.1 | 1.0 | GO:0018095 | protein polyglutamylation(GO:0018095) |
| 0.1 | 0.6 | GO:0038063 | collagen-activated tyrosine kinase receptor signaling pathway(GO:0038063) |
| 0.1 | 3.1 | GO:0032728 | positive regulation of interferon-beta production(GO:0032728) |
| 0.1 | 0.4 | GO:0042760 | very long-chain fatty acid catabolic process(GO:0042760) |
| 0.1 | 1.7 | GO:1901385 | regulation of voltage-gated calcium channel activity(GO:1901385) |
| 0.1 | 0.6 | GO:0070586 | cell-cell adhesion involved in gastrulation(GO:0070586) |
| 0.1 | 0.7 | GO:0098706 | ferric iron import into cell(GO:0097461) ferric iron import across plasma membrane(GO:0098706) |
| 0.1 | 0.3 | GO:0071798 | response to prostaglandin D(GO:0071798) cellular response to prostaglandin D stimulus(GO:0071799) |
| 0.1 | 0.9 | GO:0060136 | embryonic process involved in female pregnancy(GO:0060136) |
| 0.1 | 0.7 | GO:0046784 | viral mRNA export from host cell nucleus(GO:0046784) |
| 0.1 | 1.2 | GO:2000009 | negative regulation of protein localization to cell surface(GO:2000009) |
| 0.1 | 0.3 | GO:0006269 | DNA replication, synthesis of RNA primer(GO:0006269) leading strand elongation(GO:0006272) |
| 0.1 | 0.4 | GO:0051974 | negative regulation of telomerase activity(GO:0051974) |
| 0.1 | 0.8 | GO:0045721 | negative regulation of gluconeogenesis(GO:0045721) |
| 0.1 | 0.4 | GO:0000076 | DNA replication checkpoint(GO:0000076) |
| 0.1 | 2.0 | GO:0032012 | ARF protein signal transduction(GO:0032011) regulation of ARF protein signal transduction(GO:0032012) |
| 0.1 | 0.3 | GO:0003356 | regulation of cilium movement(GO:0003352) regulation of cilium beat frequency(GO:0003356) |
| 0.1 | 0.5 | GO:0051697 | protein delipidation(GO:0051697) |
| 0.1 | 0.5 | GO:0043117 | positive regulation of vascular permeability(GO:0043117) |
| 0.1 | 1.3 | GO:0032098 | regulation of appetite(GO:0032098) |
| 0.1 | 0.1 | GO:0002759 | regulation of antimicrobial humoral response(GO:0002759) |
| 0.1 | 2.4 | GO:0090280 | positive regulation of calcium ion import(GO:0090280) |
| 0.1 | 0.3 | GO:2000252 | negative regulation of feeding behavior(GO:2000252) |
| 0.1 | 0.3 | GO:0023041 | neuronal signal transduction(GO:0023041) |
| 0.1 | 0.5 | GO:0045719 | negative regulation of glycogen biosynthetic process(GO:0045719) |
| 0.1 | 4.3 | GO:0010811 | positive regulation of cell-substrate adhesion(GO:0010811) |
| 0.1 | 2.3 | GO:0042771 | intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator(GO:0042771) |
| 0.1 | 1.4 | GO:0006978 | DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator(GO:0006978) |
| 0.1 | 2.1 | GO:0035088 | establishment or maintenance of apical/basal cell polarity(GO:0035088) establishment or maintenance of bipolar cell polarity(GO:0061245) |
| 0.1 | 0.7 | GO:0045793 | positive regulation of cell size(GO:0045793) |
| 0.1 | 0.5 | GO:0061087 | positive regulation of histone H3-K27 methylation(GO:0061087) |
| 0.1 | 0.2 | GO:0042275 | error-free postreplication DNA repair(GO:0042275) |
| 0.1 | 0.2 | GO:0000715 | nucleotide-excision repair, DNA damage recognition(GO:0000715) |
| 0.1 | 0.2 | GO:0036114 | medium-chain fatty-acyl-CoA catabolic process(GO:0036114) long-chain fatty-acyl-CoA catabolic process(GO:0036116) palmitic acid metabolic process(GO:1900533) palmitic acid biosynthetic process(GO:1900535) |
| 0.1 | 0.9 | GO:0032367 | intracellular sterol transport(GO:0032366) intracellular cholesterol transport(GO:0032367) |
| 0.1 | 0.8 | GO:0035025 | positive regulation of Rho protein signal transduction(GO:0035025) |
| 0.1 | 0.4 | GO:0010592 | positive regulation of lamellipodium assembly(GO:0010592) |
| 0.1 | 0.3 | GO:0006450 | regulation of translational fidelity(GO:0006450) |
| 0.1 | 1.0 | GO:0043516 | regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043516) |
| 0.1 | 0.3 | GO:0010766 | negative regulation of sodium ion transport(GO:0010766) |
| 0.1 | 2.5 | GO:0048278 | vesicle docking(GO:0048278) |
| 0.1 | 0.2 | GO:0070601 | centromeric sister chromatid cohesion(GO:0070601) |
| 0.1 | 0.9 | GO:0045022 | early endosome to late endosome transport(GO:0045022) |
| 0.1 | 0.5 | GO:0046697 | decidualization(GO:0046697) |
| 0.1 | 0.4 | GO:0070417 | cellular response to cold(GO:0070417) |
| 0.1 | 0.3 | GO:1900042 | positive regulation of interleukin-2 secretion(GO:1900042) |
| 0.1 | 0.4 | GO:0000056 | ribosomal small subunit export from nucleus(GO:0000056) |
| 0.1 | 1.3 | GO:0006743 | ubiquinone metabolic process(GO:0006743) |
| 0.1 | 0.9 | GO:0071786 | endoplasmic reticulum tubular network organization(GO:0071786) |
| 0.1 | 0.2 | GO:0060235 | lens induction in camera-type eye(GO:0060235) |
| 0.1 | 0.4 | GO:0019262 | N-acetylneuraminate catabolic process(GO:0019262) |
| 0.1 | 0.9 | GO:0010971 | positive regulation of G2/M transition of mitotic cell cycle(GO:0010971) |
| 0.1 | 0.2 | GO:1902047 | polyamine transmembrane transport(GO:1902047) regulation of polyamine transmembrane transport(GO:1902267) negative regulation of polyamine transmembrane transport(GO:1902268) |
| 0.1 | 0.6 | GO:0099514 | anterograde synaptic vesicle transport(GO:0048490) synaptic vesicle cytoskeletal transport(GO:0099514) synaptic vesicle transport along microtubule(GO:0099517) |
| 0.1 | 0.7 | GO:0001675 | acrosome assembly(GO:0001675) |
| 0.1 | 0.4 | GO:0001731 | formation of translation preinitiation complex(GO:0001731) |
| 0.1 | 0.1 | GO:0070194 | synaptonemal complex disassembly(GO:0070194) positive regulation of calcium-transporting ATPase activity(GO:1901896) |
| 0.1 | 0.4 | GO:0070970 | interleukin-2 secretion(GO:0070970) |
| 0.1 | 0.5 | GO:0030262 | cellular component disassembly involved in execution phase of apoptosis(GO:0006921) apoptotic nuclear changes(GO:0030262) |
| 0.1 | 0.3 | GO:0097178 | ruffle assembly(GO:0097178) |
| 0.1 | 0.5 | GO:0035411 | catenin import into nucleus(GO:0035411) |
| 0.1 | 2.5 | GO:0032418 | lysosome localization(GO:0032418) |
| 0.1 | 0.2 | GO:0007290 | spermatid nucleus elongation(GO:0007290) |
| 0.0 | 0.4 | GO:0045063 | T-helper 1 cell differentiation(GO:0045063) |
| 0.0 | 0.8 | GO:0007220 | Notch receptor processing(GO:0007220) |
| 0.0 | 0.7 | GO:0002028 | regulation of sodium ion transport(GO:0002028) |
| 0.0 | 0.3 | GO:0033574 | response to testosterone(GO:0033574) |
| 0.0 | 0.1 | GO:0007403 | glial cell fate determination(GO:0007403) |
| 0.0 | 0.2 | GO:2000253 | positive regulation of feeding behavior(GO:2000253) |
| 0.0 | 1.6 | GO:0046513 | ceramide biosynthetic process(GO:0046513) |
| 0.0 | 1.0 | GO:0021795 | cerebral cortex cell migration(GO:0021795) |
| 0.0 | 2.8 | GO:0007218 | neuropeptide signaling pathway(GO:0007218) |
| 0.0 | 0.1 | GO:0048341 | paraxial mesoderm formation(GO:0048341) |
| 0.0 | 0.9 | GO:0048172 | regulation of short-term neuronal synaptic plasticity(GO:0048172) |
| 0.0 | 0.8 | GO:0048255 | mRNA stabilization(GO:0048255) |
| 0.0 | 1.7 | GO:0002474 | antigen processing and presentation of peptide antigen via MHC class I(GO:0002474) |
| 0.0 | 0.2 | GO:0071955 | recycling endosome to Golgi transport(GO:0071955) |
| 0.0 | 1.5 | GO:0008347 | glial cell migration(GO:0008347) |
| 0.0 | 0.3 | GO:1902856 | negative regulation of nonmotile primary cilium assembly(GO:1902856) |
| 0.0 | 0.4 | GO:0002548 | monocyte chemotaxis(GO:0002548) |
| 0.0 | 0.7 | GO:0001967 | suckling behavior(GO:0001967) |
| 0.0 | 0.2 | GO:0007256 | activation of JNKK activity(GO:0007256) |
| 0.0 | 0.6 | GO:1901028 | regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway(GO:1901028) |
| 0.0 | 2.7 | GO:0048525 | negative regulation of viral process(GO:0048525) |
| 0.0 | 1.6 | GO:0006829 | zinc II ion transport(GO:0006829) |
| 0.0 | 1.6 | GO:0007044 | cell-substrate junction assembly(GO:0007044) |
| 0.0 | 1.6 | GO:0033209 | tumor necrosis factor-mediated signaling pathway(GO:0033209) |
| 0.0 | 1.4 | GO:2000649 | regulation of sodium ion transmembrane transporter activity(GO:2000649) |
| 0.0 | 0.6 | GO:0036065 | fucosylation(GO:0036065) |
| 0.0 | 0.1 | GO:0002884 | regulation of type IV hypersensitivity(GO:0001807) negative regulation of hypersensitivity(GO:0002884) |
| 0.0 | 0.2 | GO:0051388 | positive regulation of neurotrophin TRK receptor signaling pathway(GO:0051388) |
| 0.0 | 0.3 | GO:0002295 | T-helper cell lineage commitment(GO:0002295) T-helper 17 cell lineage commitment(GO:0072540) |
| 0.0 | 0.7 | GO:0045830 | positive regulation of isotype switching(GO:0045830) |
| 0.0 | 0.1 | GO:1903433 | regulation of constitutive secretory pathway(GO:1903433) |
| 0.0 | 0.1 | GO:0043490 | malate-aspartate shuttle(GO:0043490) |
| 0.0 | 0.4 | GO:0050891 | multicellular organismal water homeostasis(GO:0050891) |
| 0.0 | 0.7 | GO:0007173 | epidermal growth factor receptor signaling pathway(GO:0007173) |
| 0.0 | 0.3 | GO:0050862 | positive regulation of T cell receptor signaling pathway(GO:0050862) |
| 0.0 | 1.0 | GO:0034508 | centromere complex assembly(GO:0034508) |
| 0.0 | 0.1 | GO:0045950 | regulation of mitotic recombination(GO:0000019) negative regulation of mitotic recombination(GO:0045950) |
| 0.0 | 0.1 | GO:0072137 | condensed mesenchymal cell proliferation(GO:0072137) |
| 0.0 | 0.2 | GO:0042167 | porphyrin-containing compound catabolic process(GO:0006787) tetrapyrrole catabolic process(GO:0033015) heme catabolic process(GO:0042167) pigment catabolic process(GO:0046149) |
| 0.0 | 0.3 | GO:0046477 | glycosylceramide catabolic process(GO:0046477) |
| 0.0 | 2.2 | GO:0007157 | heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0007157) |
| 0.0 | 0.1 | GO:0070086 | ubiquitin-dependent endocytosis(GO:0070086) |
| 0.0 | 0.2 | GO:0090084 | negative regulation of inclusion body assembly(GO:0090084) |
| 0.0 | 0.4 | GO:0070072 | proton-transporting V-type ATPase complex assembly(GO:0070070) vacuolar proton-transporting V-type ATPase complex assembly(GO:0070072) |
| 0.0 | 0.3 | GO:0016926 | protein desumoylation(GO:0016926) |
| 0.0 | 0.5 | GO:0008608 | attachment of spindle microtubules to kinetochore(GO:0008608) |
| 0.0 | 2.4 | GO:0008544 | epidermis development(GO:0008544) |
| 0.0 | 0.2 | GO:0060742 | epithelial cell differentiation involved in prostate gland development(GO:0060742) |
| 0.0 | 4.3 | GO:0006911 | phagocytosis, engulfment(GO:0006911) |
| 0.0 | 0.6 | GO:0046339 | diacylglycerol metabolic process(GO:0046339) |
| 0.0 | 0.3 | GO:2000060 | positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:2000060) |
| 0.0 | 3.8 | GO:0006936 | muscle contraction(GO:0006936) |
| 0.0 | 0.3 | GO:0031119 | tRNA pseudouridine synthesis(GO:0031119) |
| 0.0 | 1.7 | GO:0051782 | negative regulation of cell division(GO:0051782) |
| 0.0 | 0.3 | GO:0032094 | response to food(GO:0032094) |
| 0.0 | 0.4 | GO:0034205 | beta-amyloid formation(GO:0034205) |
| 0.0 | 1.6 | GO:1900181 | negative regulation of protein localization to nucleus(GO:1900181) |
| 0.0 | 0.1 | GO:0001542 | ovulation from ovarian follicle(GO:0001542) |
| 0.0 | 0.7 | GO:0032611 | interleukin-1 beta production(GO:0032611) |
| 0.0 | 0.6 | GO:0060351 | cartilage development involved in endochondral bone morphogenesis(GO:0060351) |
| 0.0 | 0.1 | GO:0019858 | cytosine metabolic process(GO:0019858) |
| 0.0 | 0.5 | GO:0030322 | stabilization of membrane potential(GO:0030322) |
| 0.0 | 0.2 | GO:0070166 | enamel mineralization(GO:0070166) |
| 0.0 | 0.3 | GO:1901250 | lung goblet cell differentiation(GO:0060480) regulation of lung goblet cell differentiation(GO:1901249) negative regulation of lung goblet cell differentiation(GO:1901250) |
| 0.0 | 0.8 | GO:1903146 | regulation of mitophagy(GO:1903146) |
| 0.0 | 0.6 | GO:0035329 | hippo signaling(GO:0035329) |
| 0.0 | 1.8 | GO:0043123 | positive regulation of I-kappaB kinase/NF-kappaB signaling(GO:0043123) |
| 0.0 | 1.8 | GO:0055013 | cardiac muscle cell development(GO:0055013) |
| 0.0 | 3.4 | GO:0007266 | Rho protein signal transduction(GO:0007266) |
| 0.0 | 0.5 | GO:2001244 | positive regulation of intrinsic apoptotic signaling pathway(GO:2001244) |
| 0.0 | 0.7 | GO:0048013 | ephrin receptor signaling pathway(GO:0048013) |
| 0.0 | 0.4 | GO:0046677 | response to antibiotic(GO:0046677) |
| 0.0 | 0.3 | GO:0006614 | SRP-dependent cotranslational protein targeting to membrane(GO:0006614) |
| 0.0 | 1.1 | GO:0032091 | negative regulation of protein binding(GO:0032091) |
| 0.0 | 0.1 | GO:2000810 | regulation of bicellular tight junction assembly(GO:2000810) |
| 0.0 | 0.6 | GO:1902850 | mitotic spindle assembly(GO:0090307) microtubule cytoskeleton organization involved in mitosis(GO:1902850) |
| 0.0 | 0.1 | GO:0048199 | vesicle targeting, to, from or within Golgi(GO:0048199) |
| 0.0 | 0.0 | GO:0090245 | axis elongation involved in somitogenesis(GO:0090245) |
| 0.0 | 1.6 | GO:0018107 | peptidyl-threonine phosphorylation(GO:0018107) |
| 0.0 | 0.5 | GO:0015985 | energy coupled proton transport, down electrochemical gradient(GO:0015985) ATP synthesis coupled proton transport(GO:0015986) |
| 0.0 | 0.1 | GO:0071340 | skeletal muscle acetylcholine-gated channel clustering(GO:0071340) |
| 0.0 | 0.1 | GO:0038128 | ERBB2 signaling pathway(GO:0038128) |
| 0.0 | 0.1 | GO:0035279 | mRNA cleavage involved in gene silencing by miRNA(GO:0035279) mRNA cleavage involved in gene silencing(GO:0098795) |
| 0.0 | 3.4 | GO:0010466 | negative regulation of peptidase activity(GO:0010466) |
| 0.0 | 0.4 | GO:0018345 | protein palmitoylation(GO:0018345) |
| 0.0 | 0.3 | GO:0045662 | negative regulation of myoblast differentiation(GO:0045662) |
| 0.0 | 0.0 | GO:0046604 | positive regulation of mitotic centrosome separation(GO:0046604) |
| 0.0 | 1.1 | GO:0002181 | cytoplasmic translation(GO:0002181) |
| 0.0 | 0.1 | GO:0010739 | positive regulation of protein kinase A signaling(GO:0010739) |
| 0.0 | 0.3 | GO:0035335 | peptidyl-tyrosine dephosphorylation(GO:0035335) |
| 0.0 | 0.2 | GO:0045292 | mRNA cis splicing, via spliceosome(GO:0045292) |
| 0.0 | 0.1 | GO:0030206 | chondroitin sulfate biosynthetic process(GO:0030206) |
| 0.0 | 0.1 | GO:0036342 | post-anal tail morphogenesis(GO:0036342) |
| 0.0 | 0.5 | GO:0045445 | myoblast differentiation(GO:0045445) |
| 0.0 | 0.1 | GO:0071110 | protein biotinylation(GO:0009305) response to biotin(GO:0070781) histone biotinylation(GO:0071110) |
| 0.0 | 0.2 | GO:0006123 | mitochondrial electron transport, cytochrome c to oxygen(GO:0006123) |
| 0.0 | 0.0 | GO:0048549 | positive regulation of pinocytosis(GO:0048549) |
| 0.0 | 0.1 | GO:0032875 | regulation of DNA endoreduplication(GO:0032875) negative regulation of DNA endoreduplication(GO:0032876) DNA endoreduplication(GO:0042023) |
| 0.0 | 0.5 | GO:0018196 | peptidyl-asparagine modification(GO:0018196) protein N-linked glycosylation via asparagine(GO:0018279) |
Gene overrepresentation in cellular component category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 4.0 | 12.1 | GO:1990667 | PCSK9-AnxA2 complex(GO:1990667) |
| 3.3 | 16.6 | GO:0005914 | spot adherens junction(GO:0005914) |
| 3.2 | 19.0 | GO:0031523 | Myb complex(GO:0031523) |
| 2.6 | 23.3 | GO:1990357 | terminal web(GO:1990357) |
| 2.5 | 7.4 | GO:0098592 | cytoplasmic side of apical plasma membrane(GO:0098592) |
| 1.7 | 22.2 | GO:0097427 | microtubule bundle(GO:0097427) |
| 1.6 | 26.5 | GO:0001527 | microfibril(GO:0001527) fibril(GO:0043205) |
| 1.5 | 5.9 | GO:0097169 | AIM2 inflammasome complex(GO:0097169) |
| 1.4 | 30.4 | GO:0031143 | pseudopodium(GO:0031143) |
| 1.4 | 21.0 | GO:0005862 | muscle thin filament tropomyosin(GO:0005862) |
| 1.3 | 6.3 | GO:0097209 | epidermal lamellar body(GO:0097209) |
| 1.2 | 3.7 | GO:0005854 | nascent polypeptide-associated complex(GO:0005854) |
| 1.2 | 3.6 | GO:0043219 | lateral loop(GO:0043219) |
| 1.2 | 20.8 | GO:0090543 | Flemming body(GO:0090543) |
| 1.1 | 3.4 | GO:0005588 | collagen type V trimer(GO:0005588) |
| 1.0 | 2.9 | GO:1990879 | CST complex(GO:1990879) |
| 1.0 | 3.9 | GO:0044393 | microspike(GO:0044393) |
| 0.9 | 1.9 | GO:0097342 | ripoptosome(GO:0097342) |
| 0.9 | 2.7 | GO:0031904 | endosome lumen(GO:0031904) |
| 0.9 | 5.3 | GO:0044279 | other organism cell membrane(GO:0044218) other organism membrane(GO:0044279) |
| 0.8 | 34.5 | GO:0045095 | keratin filament(GO:0045095) |
| 0.8 | 11.7 | GO:0042599 | lamellar body(GO:0042599) |
| 0.8 | 5.4 | GO:0042629 | mast cell granule(GO:0042629) |
| 0.7 | 2.9 | GO:0000942 | condensed nuclear chromosome outer kinetochore(GO:0000942) |
| 0.7 | 2.9 | GO:0035976 | AP1 complex(GO:0035976) |
| 0.7 | 2.9 | GO:0097444 | spine apparatus(GO:0097444) |
| 0.7 | 5.8 | GO:0044299 | C-fiber(GO:0044299) |
| 0.7 | 7.9 | GO:1990812 | growth cone lamellipodium(GO:1990761) growth cone filopodium(GO:1990812) |
| 0.7 | 2.8 | GO:0034666 | integrin alpha2-beta1 complex(GO:0034666) |
| 0.7 | 20.8 | GO:0030056 | hemidesmosome(GO:0030056) |
| 0.7 | 20.6 | GO:0030057 | desmosome(GO:0030057) |
| 0.7 | 5.4 | GO:0098837 | postsynaptic recycling endosome(GO:0098837) |
| 0.6 | 18.2 | GO:0035686 | sperm fibrous sheath(GO:0035686) |
| 0.6 | 11.8 | GO:0005861 | troponin complex(GO:0005861) |
| 0.6 | 10.5 | GO:0034098 | VCP-NPL4-UFD1 AAA ATPase complex(GO:0034098) |
| 0.6 | 2.4 | GO:0014802 | terminal cisterna(GO:0014802) |
| 0.6 | 6.0 | GO:0030314 | junctional membrane complex(GO:0030314) |
| 0.6 | 12.9 | GO:0005640 | nuclear outer membrane(GO:0005640) |
| 0.6 | 0.6 | GO:0034665 | integrin alpha1-beta1 complex(GO:0034665) |
| 0.6 | 12.8 | GO:0042589 | zymogen granule membrane(GO:0042589) |
| 0.6 | 8.9 | GO:0042588 | zymogen granule(GO:0042588) |
| 0.6 | 3.9 | GO:0031466 | Cul5-RING ubiquitin ligase complex(GO:0031466) |
| 0.5 | 7.5 | GO:0031258 | lamellipodium membrane(GO:0031258) |
| 0.5 | 10.1 | GO:0042581 | specific granule(GO:0042581) |
| 0.5 | 4.2 | GO:0005927 | muscle tendon junction(GO:0005927) |
| 0.5 | 3.0 | GO:0090498 | extrinsic component of Golgi membrane(GO:0090498) |
| 0.5 | 8.8 | GO:1990023 | mitotic spindle midzone(GO:1990023) |
| 0.5 | 7.2 | GO:0000137 | Golgi cis cisterna(GO:0000137) |
| 0.5 | 1.4 | GO:1902560 | GMP reductase complex(GO:1902560) |
| 0.5 | 2.3 | GO:0043293 | apoptosome(GO:0043293) |
| 0.5 | 103.9 | GO:0031234 | extrinsic component of cytoplasmic side of plasma membrane(GO:0031234) |
| 0.4 | 1.7 | GO:0001740 | Barr body(GO:0001740) |
| 0.4 | 1.3 | GO:0070435 | Shc-EGFR complex(GO:0070435) |
| 0.4 | 1.7 | GO:0002111 | BRCA2-BRAF35 complex(GO:0002111) |
| 0.4 | 21.1 | GO:0031902 | late endosome membrane(GO:0031902) |
| 0.4 | 5.0 | GO:0005915 | zonula adherens(GO:0005915) |
| 0.4 | 0.4 | GO:0030905 | retromer, tubulation complex(GO:0030905) |
| 0.4 | 2.8 | GO:1990246 | uniplex complex(GO:1990246) |
| 0.4 | 2.0 | GO:0016602 | CCAAT-binding factor complex(GO:0016602) |
| 0.4 | 1.5 | GO:0031417 | NatC complex(GO:0031417) |
| 0.4 | 5.8 | GO:0045180 | basal cortex(GO:0045180) |
| 0.4 | 1.5 | GO:0000221 | vacuolar proton-transporting V-type ATPase, V1 domain(GO:0000221) |
| 0.4 | 1.9 | GO:0005945 | 6-phosphofructokinase complex(GO:0005945) |
| 0.4 | 2.7 | GO:0036195 | muscle cell projection(GO:0036194) muscle cell projection membrane(GO:0036195) |
| 0.4 | 1.9 | GO:0035189 | Rb-E2F complex(GO:0035189) |
| 0.4 | 1.9 | GO:0000799 | nuclear condensin complex(GO:0000799) |
| 0.4 | 3.0 | GO:0005766 | primary lysosome(GO:0005766) azurophil granule(GO:0042582) |
| 0.4 | 3.0 | GO:0071439 | clathrin complex(GO:0071439) |
| 0.4 | 3.7 | GO:0044214 | spanning component of plasma membrane(GO:0044214) spanning component of membrane(GO:0089717) |
| 0.4 | 1.1 | GO:1990622 | CHOP-ATF3 complex(GO:1990622) |
| 0.4 | 7.6 | GO:0016600 | flotillin complex(GO:0016600) |
| 0.4 | 8.3 | GO:0005865 | striated muscle thin filament(GO:0005865) |
| 0.4 | 2.1 | GO:0032591 | dendritic spine membrane(GO:0032591) |
| 0.4 | 9.9 | GO:0090665 | dystrophin-associated glycoprotein complex(GO:0016010) glycoprotein complex(GO:0090665) |
| 0.4 | 4.6 | GO:0097512 | cardiac myofibril(GO:0097512) |
| 0.3 | 3.7 | GO:0070531 | BRCA1-A complex(GO:0070531) |
| 0.3 | 15.2 | GO:0043034 | costamere(GO:0043034) |
| 0.3 | 39.1 | GO:0032432 | actin filament bundle(GO:0032432) |
| 0.3 | 7.8 | GO:0046930 | pore complex(GO:0046930) |
| 0.3 | 0.9 | GO:0048179 | activin receptor complex(GO:0048179) |
| 0.3 | 5.5 | GO:0036038 | MKS complex(GO:0036038) |
| 0.3 | 2.7 | GO:0033093 | Weibel-Palade body(GO:0033093) |
| 0.3 | 0.6 | GO:0005863 | striated muscle myosin thick filament(GO:0005863) |
| 0.3 | 1.7 | GO:0005968 | Rab-protein geranylgeranyltransferase complex(GO:0005968) |
| 0.3 | 4.3 | GO:0031528 | microvillus membrane(GO:0031528) |
| 0.3 | 0.8 | GO:0020018 | ciliary pocket(GO:0020016) ciliary pocket membrane(GO:0020018) |
| 0.3 | 2.0 | GO:0070938 | contractile ring(GO:0070938) |
| 0.3 | 5.5 | GO:0033017 | sarcoplasmic reticulum membrane(GO:0033017) |
| 0.3 | 1.4 | GO:0045160 | myosin I complex(GO:0045160) |
| 0.3 | 1.9 | GO:0030485 | smooth muscle contractile fiber(GO:0030485) |
| 0.3 | 22.1 | GO:0034707 | chloride channel complex(GO:0034707) |
| 0.3 | 2.4 | GO:0072357 | PTW/PP1 phosphatase complex(GO:0072357) |
| 0.3 | 3.1 | GO:0008250 | oligosaccharyltransferase complex(GO:0008250) |
| 0.3 | 1.3 | GO:0070442 | integrin alphaIIb-beta3 complex(GO:0070442) |
| 0.3 | 1.5 | GO:1990356 | sumoylated E2 ligase complex(GO:1990356) |
| 0.2 | 0.5 | GO:1990666 | PCSK9-LDLR complex(GO:1990666) |
| 0.2 | 9.6 | GO:0097610 | cleavage furrow(GO:0032154) cell surface furrow(GO:0097610) |
| 0.2 | 1.7 | GO:0005638 | lamin filament(GO:0005638) |
| 0.2 | 3.6 | GO:0048787 | presynaptic active zone membrane(GO:0048787) |
| 0.2 | 21.6 | GO:0030864 | cortical actin cytoskeleton(GO:0030864) |
| 0.2 | 0.7 | GO:0005832 | chaperonin-containing T-complex(GO:0005832) |
| 0.2 | 0.7 | GO:0032593 | insulin-responsive compartment(GO:0032593) |
| 0.2 | 5.7 | GO:0005605 | basal lamina(GO:0005605) |
| 0.2 | 5.7 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
| 0.2 | 2.8 | GO:0005652 | nuclear lamina(GO:0005652) |
| 0.2 | 2.4 | GO:0031527 | filopodium membrane(GO:0031527) |
| 0.2 | 3.1 | GO:0005641 | nuclear envelope lumen(GO:0005641) |
| 0.2 | 5.3 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
| 0.2 | 5.2 | GO:0055038 | recycling endosome membrane(GO:0055038) |
| 0.2 | 1.0 | GO:0016222 | procollagen-proline 4-dioxygenase complex(GO:0016222) |
| 0.2 | 2.6 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
| 0.2 | 4.3 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
| 0.2 | 2.1 | GO:0000815 | ESCRT III complex(GO:0000815) |
| 0.2 | 32.7 | GO:0005923 | bicellular tight junction(GO:0005923) |
| 0.2 | 1.7 | GO:1990454 | L-type voltage-gated calcium channel complex(GO:1990454) |
| 0.2 | 0.6 | GO:0031205 | endoplasmic reticulum Sec complex(GO:0031205) |
| 0.2 | 1.9 | GO:0048500 | signal recognition particle(GO:0048500) |
| 0.2 | 6.8 | GO:0005921 | gap junction(GO:0005921) |
| 0.2 | 0.2 | GO:0035867 | alphav-beta3 integrin-IGF-1-IGF1R complex(GO:0035867) |
| 0.2 | 7.1 | GO:0031012 | extracellular matrix(GO:0031012) |
| 0.2 | 1.6 | GO:0031211 | serine C-palmitoyltransferase complex(GO:0017059) endoplasmic reticulum palmitoyltransferase complex(GO:0031211) |
| 0.2 | 10.9 | GO:0022627 | cytosolic small ribosomal subunit(GO:0022627) |
| 0.2 | 2.2 | GO:0033256 | I-kappaB/NF-kappaB complex(GO:0033256) |
| 0.2 | 1.0 | GO:0046696 | lipopolysaccharide receptor complex(GO:0046696) |
| 0.2 | 1.7 | GO:0005642 | annulate lamellae(GO:0005642) |
| 0.2 | 7.9 | GO:0031901 | early endosome membrane(GO:0031901) |
| 0.2 | 0.7 | GO:0035101 | FACT complex(GO:0035101) |
| 0.2 | 1.1 | GO:0001931 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
| 0.2 | 69.3 | GO:0030055 | focal adhesion(GO:0005925) cell-substrate junction(GO:0030055) |
| 0.2 | 5.9 | GO:0030175 | filopodium(GO:0030175) |
| 0.2 | 4.9 | GO:0005614 | interstitial matrix(GO:0005614) |
| 0.2 | 0.6 | GO:0071148 | TEAD-1-YAP complex(GO:0071148) |
| 0.2 | 14.2 | GO:0032587 | ruffle membrane(GO:0032587) |
| 0.2 | 0.6 | GO:1990769 | proximal neuron projection(GO:1990769) |
| 0.2 | 1.7 | GO:0005664 | origin recognition complex(GO:0000808) nuclear origin of replication recognition complex(GO:0005664) |
| 0.2 | 5.5 | GO:0031672 | A band(GO:0031672) |
| 0.2 | 13.7 | GO:0030018 | Z disc(GO:0030018) |
| 0.1 | 7.6 | GO:0005788 | endoplasmic reticulum lumen(GO:0005788) |
| 0.1 | 3.2 | GO:0005790 | smooth endoplasmic reticulum(GO:0005790) |
| 0.1 | 1.5 | GO:0071141 | SMAD protein complex(GO:0071141) |
| 0.1 | 4.1 | GO:0005779 | integral component of peroxisomal membrane(GO:0005779) |
| 0.1 | 2.0 | GO:0097470 | ribbon synapse(GO:0097470) |
| 0.1 | 1.9 | GO:0042612 | MHC class I protein complex(GO:0042612) |
| 0.1 | 7.2 | GO:0001533 | cornified envelope(GO:0001533) |
| 0.1 | 0.4 | GO:0031372 | UBC13-MMS2 complex(GO:0031372) |
| 0.1 | 1.0 | GO:0097386 | glial cell projection(GO:0097386) |
| 0.1 | 0.4 | GO:0032998 | Fc receptor complex(GO:0032997) Fc-epsilon receptor I complex(GO:0032998) |
| 0.1 | 2.4 | GO:0002102 | podosome(GO:0002102) |
| 0.1 | 0.5 | GO:0008278 | cohesin complex(GO:0008278) |
| 0.1 | 1.0 | GO:0034993 | microtubule organizing center attachment site(GO:0034992) LINC complex(GO:0034993) |
| 0.1 | 0.4 | GO:0000811 | GINS complex(GO:0000811) |
| 0.1 | 5.1 | GO:0005902 | microvillus(GO:0005902) |
| 0.1 | 3.3 | GO:0016529 | sarcoplasmic reticulum(GO:0016529) |
| 0.1 | 2.8 | GO:0005666 | DNA-directed RNA polymerase III complex(GO:0005666) |
| 0.1 | 0.6 | GO:0098645 | collagen type IV trimer(GO:0005587) network-forming collagen trimer(GO:0098642) collagen network(GO:0098645) basement membrane collagen trimer(GO:0098651) |
| 0.1 | 0.8 | GO:0045254 | pyruvate dehydrogenase complex(GO:0045254) |
| 0.1 | 0.6 | GO:0097057 | TRAF2-GSTP1 complex(GO:0097057) |
| 0.1 | 3.0 | GO:0030140 | trans-Golgi network transport vesicle(GO:0030140) |
| 0.1 | 3.9 | GO:0035371 | microtubule plus-end(GO:0035371) |
| 0.1 | 2.0 | GO:0000506 | glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex(GO:0000506) |
| 0.1 | 0.5 | GO:0097058 | CRLF-CLCF1 complex(GO:0097058) |
| 0.1 | 0.4 | GO:0042583 | chromaffin granule(GO:0042583) |
| 0.1 | 0.9 | GO:0070765 | gamma-secretase complex(GO:0070765) |
| 0.1 | 1.1 | GO:0072669 | tRNA-splicing ligase complex(GO:0072669) |
| 0.1 | 0.7 | GO:0070695 | FHF complex(GO:0070695) |
| 0.1 | 0.6 | GO:0000220 | vacuolar proton-transporting V-type ATPase, V0 domain(GO:0000220) |
| 0.1 | 0.5 | GO:0031262 | Ndc80 complex(GO:0031262) |
| 0.1 | 6.8 | GO:0031970 | mitochondrial intermembrane space(GO:0005758) organelle envelope lumen(GO:0031970) |
| 0.1 | 1.1 | GO:0070578 | micro-ribonucleoprotein complex(GO:0035068) RISC-loading complex(GO:0070578) |
| 0.1 | 1.3 | GO:0016589 | NURF complex(GO:0016589) |
| 0.1 | 35.1 | GO:0005578 | proteinaceous extracellular matrix(GO:0005578) |
| 0.1 | 0.3 | GO:0036398 | TCR signalosome(GO:0036398) |
| 0.1 | 1.0 | GO:0030015 | CCR4-NOT core complex(GO:0030015) |
| 0.1 | 19.6 | GO:0044455 | mitochondrial membrane part(GO:0044455) |
| 0.1 | 1.6 | GO:0051233 | spindle midzone(GO:0051233) |
| 0.1 | 7.1 | GO:0005901 | caveola(GO:0005901) |
| 0.1 | 1.2 | GO:0030014 | CCR4-NOT complex(GO:0030014) |
| 0.1 | 0.7 | GO:0000347 | THO complex(GO:0000347) THO complex part of transcription export complex(GO:0000445) |
| 0.1 | 1.0 | GO:0034709 | methylosome(GO:0034709) |
| 0.1 | 1.6 | GO:0097038 | perinuclear endoplasmic reticulum(GO:0097038) |
| 0.1 | 16.4 | GO:0098857 | membrane raft(GO:0045121) membrane microdomain(GO:0098857) |
| 0.1 | 1.5 | GO:0031941 | filamentous actin(GO:0031941) |
| 0.1 | 3.0 | GO:0005719 | nuclear euchromatin(GO:0005719) |
| 0.1 | 0.3 | GO:0032982 | myosin filament(GO:0032982) |
| 0.1 | 0.7 | GO:0030123 | AP-3 adaptor complex(GO:0030123) |
| 0.1 | 0.4 | GO:0030896 | checkpoint clamp complex(GO:0030896) |
| 0.1 | 0.6 | GO:0000940 | condensed chromosome outer kinetochore(GO:0000940) |
| 0.1 | 2.6 | GO:0071011 | precatalytic spliceosome(GO:0071011) |
| 0.1 | 0.7 | GO:0042641 | actomyosin(GO:0042641) |
| 0.1 | 0.2 | GO:0071007 | U2-type catalytic step 2 spliceosome(GO:0071007) |
| 0.1 | 0.4 | GO:0033116 | endoplasmic reticulum-Golgi intermediate compartment membrane(GO:0033116) |
| 0.1 | 2.4 | GO:0022625 | cytosolic large ribosomal subunit(GO:0022625) |
| 0.1 | 0.2 | GO:0071942 | XPC complex(GO:0071942) |
| 0.1 | 0.1 | GO:0005828 | kinetochore microtubule(GO:0005828) |
| 0.1 | 7.4 | GO:0042571 | immunoglobulin complex, circulating(GO:0042571) |
| 0.1 | 0.7 | GO:1904115 | axon cytoplasm(GO:1904115) |
| 0.1 | 0.7 | GO:0031209 | SCAR complex(GO:0031209) |
| 0.1 | 2.1 | GO:0008180 | COP9 signalosome(GO:0008180) |
| 0.1 | 0.3 | GO:1990111 | spermatoproteasome complex(GO:1990111) |
| 0.1 | 1.4 | GO:0071782 | endoplasmic reticulum tubular network(GO:0071782) endoplasmic reticulum subcompartment(GO:0098827) |
| 0.1 | 2.2 | GO:0016235 | aggresome(GO:0016235) |
| 0.1 | 3.9 | GO:0005795 | Golgi stack(GO:0005795) |
| 0.1 | 0.5 | GO:0008282 | ATP-sensitive potassium channel complex(GO:0008282) |
| 0.1 | 0.9 | GO:0098636 | protein complex involved in cell adhesion(GO:0098636) |
| 0.1 | 0.3 | GO:0097165 | nuclear stress granule(GO:0097165) |
| 0.1 | 0.6 | GO:0031045 | dense core granule(GO:0031045) |
| 0.1 | 0.4 | GO:0000788 | nuclear nucleosome(GO:0000788) |
| 0.1 | 0.4 | GO:0033063 | Rad51B-Rad51C-Rad51D-XRCC2 complex(GO:0033063) |
| 0.1 | 0.4 | GO:0005787 | signal peptidase complex(GO:0005787) |
| 0.1 | 142.3 | GO:0070062 | extracellular exosome(GO:0070062) |
| 0.0 | 0.1 | GO:0060053 | neurofilament cytoskeleton(GO:0060053) |
| 0.0 | 0.3 | GO:0000778 | condensed nuclear chromosome kinetochore(GO:0000778) |
| 0.0 | 0.4 | GO:0043020 | NADPH oxidase complex(GO:0043020) |
| 0.0 | 0.3 | GO:0042765 | GPI-anchor transamidase complex(GO:0042765) |
| 0.0 | 0.3 | GO:0005658 | alpha DNA polymerase:primase complex(GO:0005658) |
| 0.0 | 0.5 | GO:0017119 | Golgi transport complex(GO:0017119) |
| 0.0 | 0.5 | GO:0005868 | cytoplasmic dynein complex(GO:0005868) |
| 0.0 | 7.9 | GO:0031965 | nuclear membrane(GO:0031965) |
| 0.0 | 0.7 | GO:0016459 | myosin complex(GO:0016459) |
| 0.0 | 4.2 | GO:0016605 | PML body(GO:0016605) |
| 0.0 | 0.4 | GO:0005671 | Ada2/Gcn5/Ada3 transcription activator complex(GO:0005671) |
| 0.0 | 0.3 | GO:0036157 | outer dynein arm(GO:0036157) |
| 0.0 | 0.8 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
| 0.0 | 0.8 | GO:0031201 | SNARE complex(GO:0031201) |
| 0.0 | 0.3 | GO:0031464 | Cul4A-RING E3 ubiquitin ligase complex(GO:0031464) |
| 0.0 | 1.7 | GO:0072686 | mitotic spindle(GO:0072686) |
| 0.0 | 2.3 | GO:0016363 | nuclear matrix(GO:0016363) |
| 0.0 | 0.2 | GO:0031467 | Cul7-RING ubiquitin ligase complex(GO:0031467) |
| 0.0 | 1.5 | GO:0008023 | transcription elongation factor complex(GO:0008023) |
| 0.0 | 2.3 | GO:0005770 | late endosome(GO:0005770) |
| 0.0 | 1.4 | GO:0030496 | midbody(GO:0030496) |
| 0.0 | 0.1 | GO:0042105 | alpha-beta T cell receptor complex(GO:0042105) |
| 0.0 | 0.6 | GO:0035098 | ESC/E(Z) complex(GO:0035098) |
| 0.0 | 10.6 | GO:0009986 | cell surface(GO:0009986) |
| 0.0 | 1.1 | GO:0008076 | voltage-gated potassium channel complex(GO:0008076) |
| 0.0 | 0.1 | GO:0000796 | condensin complex(GO:0000796) |
| 0.0 | 2.3 | GO:0000775 | chromosome, centromeric region(GO:0000775) |
| 0.0 | 0.1 | GO:0005686 | U2 snRNP(GO:0005686) |
| 0.0 | 0.1 | GO:0070775 | H3 histone acetyltransferase complex(GO:0070775) MOZ/MORF histone acetyltransferase complex(GO:0070776) |
Gene overrepresentation in molecular function category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 5.6 | 22.5 | GO:0030023 | extracellular matrix constituent conferring elasticity(GO:0030023) |
| 4.9 | 14.7 | GO:0031751 | D4 dopamine receptor binding(GO:0031751) |
| 3.5 | 24.5 | GO:0004111 | creatine kinase activity(GO:0004111) |
| 3.4 | 74.6 | GO:0044548 | S100 protein binding(GO:0044548) |
| 3.3 | 6.7 | GO:0048030 | disaccharide binding(GO:0048030) |
| 3.0 | 18.3 | GO:0034988 | Fc-gamma receptor I complex binding(GO:0034988) |
| 2.9 | 11.7 | GO:0001733 | galactosylceramide sulfotransferase activity(GO:0001733) |
| 2.5 | 7.5 | GO:0098973 | structural constituent of synapse(GO:0098918) structural constituent of postsynaptic actin cytoskeleton(GO:0098973) |
| 2.3 | 7.0 | GO:0047192 | 1-alkylglycerophosphocholine O-acetyltransferase activity(GO:0047192) |
| 2.0 | 10.2 | GO:0001010 | transcription factor activity, sequence-specific DNA binding transcription factor recruiting(GO:0001010) |
| 2.0 | 5.9 | GO:0032090 | Pyrin domain binding(GO:0032090) |
| 1.8 | 10.9 | GO:0004614 | phosphoglucomutase activity(GO:0004614) |
| 1.8 | 7.2 | GO:0036132 | 13-prostaglandin reductase activity(GO:0036132) 15-oxoprostaglandin 13-oxidase activity(GO:0047522) |
| 1.7 | 10.5 | GO:0070320 | inward rectifier potassium channel inhibitor activity(GO:0070320) |
| 1.7 | 6.6 | GO:0004052 | arachidonate 12-lipoxygenase activity(GO:0004052) |
| 1.6 | 6.5 | GO:0042008 | interleukin-18 receptor activity(GO:0042008) |
| 1.6 | 9.7 | GO:0017077 | oxidative phosphorylation uncoupler activity(GO:0017077) |
| 1.5 | 4.6 | GO:0001042 | RNA polymerase I core binding(GO:0001042) |
| 1.5 | 7.3 | GO:0015254 | glycerol channel activity(GO:0015254) |
| 1.4 | 5.7 | GO:1990763 | arrestin family protein binding(GO:1990763) |
| 1.4 | 9.9 | GO:0015220 | choline transmembrane transporter activity(GO:0015220) |
| 1.3 | 5.2 | GO:0000822 | inositol hexakisphosphate binding(GO:0000822) |
| 1.3 | 7.8 | GO:0046920 | alpha-(1->3)-fucosyltransferase activity(GO:0046920) |
| 1.3 | 5.1 | GO:0015057 | thrombin receptor activity(GO:0015057) |
| 1.3 | 7.7 | GO:0048495 | Roundabout binding(GO:0048495) |
| 1.2 | 3.7 | GO:0070773 | protein-N-terminal glutamine amidohydrolase activity(GO:0070773) |
| 1.2 | 3.6 | GO:0004373 | glycogen (starch) synthase activity(GO:0004373) |
| 1.2 | 22.3 | GO:0038191 | neuropilin binding(GO:0038191) |
| 1.2 | 8.1 | GO:0010859 | calcium-dependent cysteine-type endopeptidase inhibitor activity(GO:0010859) |
| 1.2 | 10.4 | GO:0005094 | Rho GDP-dissociation inhibitor activity(GO:0005094) |
| 1.1 | 1.1 | GO:0030348 | syntaxin-3 binding(GO:0030348) |
| 1.1 | 1.1 | GO:0043183 | vascular endothelial growth factor receptor 1 binding(GO:0043183) |
| 1.1 | 10.0 | GO:0004859 | phospholipase inhibitor activity(GO:0004859) |
| 1.1 | 3.2 | GO:0050694 | galactose 3-O-sulfotransferase activity(GO:0050694) |
| 1.1 | 10.6 | GO:0031014 | troponin T binding(GO:0031014) |
| 1.1 | 3.2 | GO:0047756 | chondroitin 4-sulfotransferase activity(GO:0047756) |
| 1.1 | 11.6 | GO:0070061 | fructose binding(GO:0070061) |
| 1.0 | 33.2 | GO:0004198 | calcium-dependent cysteine-type endopeptidase activity(GO:0004198) |
| 1.0 | 3.0 | GO:0005345 | purine nucleobase transmembrane transporter activity(GO:0005345) pyrimidine nucleobase transmembrane transporter activity(GO:0005350) nucleobase transmembrane transporter activity(GO:0015205) pyrimidine- and adenine-specific:sodium symporter activity(GO:0015389) |
| 1.0 | 5.0 | GO:0004735 | pyrroline-5-carboxylate reductase activity(GO:0004735) |
| 1.0 | 12.8 | GO:0022889 | L-serine transmembrane transporter activity(GO:0015194) serine transmembrane transporter activity(GO:0022889) |
| 1.0 | 5.9 | GO:0015111 | iodide transmembrane transporter activity(GO:0015111) |
| 1.0 | 2.9 | GO:0052658 | inositol-1,4,5-trisphosphate 5-phosphatase activity(GO:0052658) |
| 1.0 | 1.9 | GO:0003872 | 6-phosphofructokinase activity(GO:0003872) |
| 1.0 | 7.6 | GO:0035727 | lysophosphatidic acid binding(GO:0035727) |
| 1.0 | 4.8 | GO:0080019 | fatty-acyl-CoA reductase (alcohol-forming) activity(GO:0080019) |
| 0.9 | 2.8 | GO:0004616 | phosphogluconate dehydrogenase (decarboxylating) activity(GO:0004616) |
| 0.9 | 6.5 | GO:0030549 | acetylcholine receptor activator activity(GO:0030549) |
| 0.9 | 7.3 | GO:0031821 | G-protein coupled serotonin receptor binding(GO:0031821) |
| 0.9 | 10.8 | GO:0005412 | glucose:sodium symporter activity(GO:0005412) |
| 0.9 | 6.2 | GO:0004090 | carbonyl reductase (NADPH) activity(GO:0004090) |
| 0.9 | 2.6 | GO:0052599 | diamine oxidase activity(GO:0052597) histamine oxidase activity(GO:0052598) methylputrescine oxidase activity(GO:0052599) propane-1,3-diamine oxidase activity(GO:0052600) |
| 0.9 | 6.9 | GO:0070290 | N-acylphosphatidylethanolamine-specific phospholipase D activity(GO:0070290) |
| 0.8 | 55.1 | GO:0008307 | structural constituent of muscle(GO:0008307) |
| 0.8 | 11.8 | GO:0042731 | PH domain binding(GO:0042731) |
| 0.8 | 2.5 | GO:0008900 | hydrogen:potassium-exchanging ATPase activity(GO:0008900) |
| 0.8 | 2.5 | GO:0004605 | phosphatidate cytidylyltransferase activity(GO:0004605) |
| 0.8 | 5.8 | GO:0004957 | prostaglandin E receptor activity(GO:0004957) |
| 0.8 | 2.4 | GO:0052593 | tryptamine:oxygen oxidoreductase (deaminating) activity(GO:0052593) aminoacetone:oxygen oxidoreductase(deaminating) activity(GO:0052594) aliphatic-amine oxidase activity(GO:0052595) phenethylamine:oxygen oxidoreductase (deaminating) activity(GO:0052596) |
| 0.8 | 3.2 | GO:0047184 | 1-acylglycerophosphocholine O-acyltransferase activity(GO:0047184) |
| 0.8 | 13.7 | GO:0048407 | platelet-derived growth factor binding(GO:0048407) |
| 0.8 | 8.0 | GO:0038132 | neuregulin binding(GO:0038132) |
| 0.8 | 2.3 | GO:0004461 | lactose synthase activity(GO:0004461) |
| 0.8 | 6.2 | GO:0004126 | cytidine deaminase activity(GO:0004126) |
| 0.8 | 3.8 | GO:0004045 | aminoacyl-tRNA hydrolase activity(GO:0004045) |
| 0.8 | 4.5 | GO:1990050 | phosphatidic acid transporter activity(GO:1990050) |
| 0.8 | 3.8 | GO:0047696 | beta-adrenergic receptor kinase activity(GO:0047696) |
| 0.7 | 3.0 | GO:0008493 | tetracycline transporter activity(GO:0008493) |
| 0.7 | 2.2 | GO:0016262 | protein N-acetylglucosaminyltransferase activity(GO:0016262) |
| 0.7 | 6.7 | GO:0047498 | calcium-dependent phospholipase A2 activity(GO:0047498) |
| 0.7 | 8.1 | GO:0004459 | L-lactate dehydrogenase activity(GO:0004459) |
| 0.7 | 20.5 | GO:0005229 | intracellular calcium activated chloride channel activity(GO:0005229) |
| 0.7 | 4.4 | GO:0004716 | receptor signaling protein tyrosine kinase activity(GO:0004716) |
| 0.7 | 2.2 | GO:0016501 | prostacyclin receptor activity(GO:0016501) |
| 0.7 | 21.1 | GO:0031489 | myosin V binding(GO:0031489) |
| 0.7 | 5.0 | GO:0042134 | rRNA primary transcript binding(GO:0042134) |
| 0.7 | 5.6 | GO:0005499 | vitamin D binding(GO:0005499) |
| 0.7 | 3.5 | GO:0004449 | isocitrate dehydrogenase (NAD+) activity(GO:0004449) |
| 0.7 | 2.0 | GO:0019153 | protein-disulfide reductase (glutathione) activity(GO:0019153) |
| 0.7 | 2.0 | GO:0051765 | inositol tetrakisphosphate kinase activity(GO:0051765) |
| 0.7 | 12.8 | GO:0008301 | DNA binding, bending(GO:0008301) |
| 0.7 | 1.3 | GO:0035276 | alcohol dehydrogenase activity, zinc-dependent(GO:0004024) ethanol binding(GO:0035276) |
| 0.7 | 2.6 | GO:1902379 | chemoattractant activity involved in axon guidance(GO:1902379) |
| 0.7 | 2.6 | GO:0051373 | FATZ binding(GO:0051373) |
| 0.7 | 2.0 | GO:0002055 | adenine binding(GO:0002055) adenine phosphoribosyltransferase activity(GO:0003999) |
| 0.6 | 3.2 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
| 0.6 | 3.2 | GO:0004974 | leukotriene receptor activity(GO:0004974) |
| 0.6 | 1.9 | GO:0033754 | indoleamine 2,3-dioxygenase activity(GO:0033754) |
| 0.6 | 1.9 | GO:0004739 | pyruvate dehydrogenase (acetyl-transferring) activity(GO:0004739) |
| 0.6 | 1.9 | GO:0034188 | apolipoprotein receptor activity(GO:0030226) apolipoprotein A-I receptor activity(GO:0034188) phosphatidylserine-translocating ATPase activity(GO:0090556) |
| 0.6 | 5.0 | GO:0060072 | large conductance calcium-activated potassium channel activity(GO:0060072) |
| 0.6 | 1.9 | GO:0008131 | primary amine oxidase activity(GO:0008131) |
| 0.6 | 4.4 | GO:1990254 | keratin filament binding(GO:1990254) |
| 0.6 | 6.2 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
| 0.6 | 5.5 | GO:0016286 | small conductance calcium-activated potassium channel activity(GO:0016286) |
| 0.6 | 16.8 | GO:0019956 | chemokine binding(GO:0019956) |
| 0.6 | 1.2 | GO:0031013 | troponin I binding(GO:0031013) |
| 0.6 | 2.3 | GO:0031708 | endothelin B receptor binding(GO:0031708) |
| 0.6 | 6.8 | GO:0001730 | 2'-5'-oligoadenylate synthetase activity(GO:0001730) |
| 0.6 | 3.4 | GO:0098639 | collagen binding involved in cell-matrix adhesion(GO:0098639) |
| 0.6 | 3.9 | GO:0008294 | calcium- and calmodulin-responsive adenylate cyclase activity(GO:0008294) |
| 0.6 | 2.2 | GO:0042284 | sphingolipid delta-4 desaturase activity(GO:0042284) |
| 0.6 | 1.1 | GO:0000405 | bubble DNA binding(GO:0000405) |
| 0.5 | 15.9 | GO:0031005 | filamin binding(GO:0031005) |
| 0.5 | 2.2 | GO:0070976 | calcium-independent protein kinase C activity(GO:0004699) TIR domain binding(GO:0070976) |
| 0.5 | 1.6 | GO:0043120 | tumor necrosis factor binding(GO:0043120) |
| 0.5 | 30.5 | GO:0005154 | epidermal growth factor receptor binding(GO:0005154) |
| 0.5 | 5.9 | GO:0005113 | patched binding(GO:0005113) |
| 0.5 | 3.2 | GO:0046624 | sphingolipid transporter activity(GO:0046624) |
| 0.5 | 1.6 | GO:0030116 | glial cell-derived neurotrophic factor receptor binding(GO:0030116) |
| 0.5 | 1.6 | GO:0097108 | hedgehog family protein binding(GO:0097108) |
| 0.5 | 36.3 | GO:0005544 | calcium-dependent phospholipid binding(GO:0005544) |
| 0.5 | 8.4 | GO:0045294 | alpha-catenin binding(GO:0045294) |
| 0.5 | 3.6 | GO:0043199 | sulfate binding(GO:0043199) |
| 0.5 | 10.0 | GO:0015095 | magnesium ion transmembrane transporter activity(GO:0015095) |
| 0.5 | 1.5 | GO:0090555 | phosphatidylethanolamine-translocating ATPase activity(GO:0090555) |
| 0.5 | 2.0 | GO:0019828 | aspartic-type endopeptidase inhibitor activity(GO:0019828) |
| 0.5 | 1.4 | GO:0052895 | norspermine:oxygen oxidoreductase activity(GO:0052894) N1-acetylspermine:oxygen oxidoreductase (N1-acetylspermidine-forming) activity(GO:0052895) |
| 0.5 | 2.4 | GO:0008859 | exoribonuclease II activity(GO:0008859) |
| 0.5 | 6.2 | GO:0050692 | DBD domain binding(GO:0050692) |
| 0.5 | 1.4 | GO:0016657 | GMP reductase activity(GO:0003920) oxidoreductase activity, acting on NAD(P)H, nitrogenous group as acceptor(GO:0016657) |
| 0.5 | 1.9 | GO:0004830 | tryptophan-tRNA ligase activity(GO:0004830) |
| 0.5 | 22.7 | GO:0003785 | actin monomer binding(GO:0003785) |
| 0.5 | 3.7 | GO:0017128 | phospholipid scramblase activity(GO:0017128) |
| 0.5 | 6.5 | GO:0030215 | semaphorin receptor binding(GO:0030215) |
| 0.5 | 4.1 | GO:0004030 | aldehyde dehydrogenase [NAD(P)+] activity(GO:0004030) |
| 0.4 | 4.0 | GO:0015129 | lactate transmembrane transporter activity(GO:0015129) |
| 0.4 | 10.7 | GO:0004708 | MAP kinase kinase activity(GO:0004708) |
| 0.4 | 2.2 | GO:0008475 | procollagen-lysine 5-dioxygenase activity(GO:0008475) |
| 0.4 | 1.8 | GO:0050347 | trans-hexaprenyltranstransferase activity(GO:0000010) trans-octaprenyltranstransferase activity(GO:0050347) |
| 0.4 | 1.7 | GO:0004517 | nitric-oxide synthase activity(GO:0004517) |
| 0.4 | 1.3 | GO:0045127 | N-acetylglucosamine kinase activity(GO:0045127) |
| 0.4 | 72.0 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
| 0.4 | 5.2 | GO:0070700 | BMP receptor binding(GO:0070700) |
| 0.4 | 1.7 | GO:0005459 | UDP-galactose transmembrane transporter activity(GO:0005459) |
| 0.4 | 5.5 | GO:0071253 | connexin binding(GO:0071253) |
| 0.4 | 6.7 | GO:0005522 | profilin binding(GO:0005522) |
| 0.4 | 3.3 | GO:0051371 | muscle alpha-actinin binding(GO:0051371) |
| 0.4 | 0.8 | GO:1990932 | 5.8S rRNA binding(GO:1990932) |
| 0.4 | 2.3 | GO:0030171 | voltage-gated proton channel activity(GO:0030171) |
| 0.4 | 13.3 | GO:0004190 | aspartic-type endopeptidase activity(GO:0004190) |
| 0.4 | 1.5 | GO:0008184 | glycogen phosphorylase activity(GO:0008184) |
| 0.4 | 4.4 | GO:0015280 | ligand-gated sodium channel activity(GO:0015280) |
| 0.4 | 6.2 | GO:0019531 | oxalate transmembrane transporter activity(GO:0019531) |
| 0.4 | 6.9 | GO:0010314 | phosphatidylinositol-5-phosphate binding(GO:0010314) |
| 0.4 | 3.2 | GO:0045545 | syndecan binding(GO:0045545) |
| 0.3 | 4.9 | GO:0005523 | tropomyosin binding(GO:0005523) |
| 0.3 | 83.7 | GO:0051015 | actin filament binding(GO:0051015) |
| 0.3 | 23.8 | GO:0004715 | non-membrane spanning protein tyrosine kinase activity(GO:0004715) |
| 0.3 | 1.0 | GO:0004615 | phosphomannomutase activity(GO:0004615) |
| 0.3 | 2.0 | GO:0033142 | progesterone receptor binding(GO:0033142) |
| 0.3 | 2.4 | GO:0016802 | adenosylhomocysteinase activity(GO:0004013) trialkylsulfonium hydrolase activity(GO:0016802) |
| 0.3 | 3.7 | GO:0016176 | superoxide-generating NADPH oxidase activator activity(GO:0016176) |
| 0.3 | 1.0 | GO:0004489 | methylenetetrahydrofolate reductase (NAD(P)H) activity(GO:0004489) |
| 0.3 | 1.0 | GO:0030519 | snoRNP binding(GO:0030519) |
| 0.3 | 7.3 | GO:0008510 | sodium:bicarbonate symporter activity(GO:0008510) |
| 0.3 | 5.6 | GO:0035497 | cAMP response element binding(GO:0035497) |
| 0.3 | 1.0 | GO:0035500 | MH2 domain binding(GO:0035500) |
| 0.3 | 1.9 | GO:0034714 | type III transforming growth factor beta receptor binding(GO:0034714) |
| 0.3 | 0.6 | GO:0015222 | serotonin transmembrane transporter activity(GO:0015222) |
| 0.3 | 2.3 | GO:0004704 | NF-kappaB-inducing kinase activity(GO:0004704) |
| 0.3 | 5.7 | GO:0003993 | acid phosphatase activity(GO:0003993) |
| 0.3 | 1.6 | GO:0004758 | serine C-palmitoyltransferase activity(GO:0004758) C-palmitoyltransferase activity(GO:0016454) |
| 0.3 | 9.1 | GO:0015002 | cytochrome-c oxidase activity(GO:0004129) heme-copper terminal oxidase activity(GO:0015002) oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor(GO:0016676) |
| 0.3 | 4.1 | GO:0005001 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) transmembrane receptor protein phosphatase activity(GO:0019198) |
| 0.3 | 1.9 | GO:0015186 | L-glutamine transmembrane transporter activity(GO:0015186) |
| 0.3 | 1.2 | GO:0008160 | protein tyrosine phosphatase activator activity(GO:0008160) |
| 0.3 | 3.4 | GO:0050700 | CARD domain binding(GO:0050700) |
| 0.3 | 0.9 | GO:0004421 | hydroxymethylglutaryl-CoA synthase activity(GO:0004421) |
| 0.3 | 2.1 | GO:0051011 | microtubule minus-end binding(GO:0051011) |
| 0.3 | 0.9 | GO:0003845 | 11-beta-hydroxysteroid dehydrogenase [NAD(P)] activity(GO:0003845) |
| 0.3 | 5.6 | GO:0045295 | gamma-catenin binding(GO:0045295) |
| 0.3 | 2.4 | GO:0043262 | adenosine-diphosphatase activity(GO:0043262) |
| 0.3 | 0.9 | GO:0003868 | 4-hydroxyphenylpyruvate dioxygenase activity(GO:0003868) |
| 0.3 | 2.1 | GO:0035374 | chondroitin sulfate binding(GO:0035374) |
| 0.3 | 7.0 | GO:0051861 | glycolipid binding(GO:0051861) |
| 0.3 | 17.4 | GO:0050840 | extracellular matrix binding(GO:0050840) |
| 0.3 | 2.3 | GO:0052654 | branched-chain-amino-acid transaminase activity(GO:0004084) L-leucine transaminase activity(GO:0052654) L-valine transaminase activity(GO:0052655) L-isoleucine transaminase activity(GO:0052656) |
| 0.3 | 2.6 | GO:0015193 | L-proline transmembrane transporter activity(GO:0015193) |
| 0.3 | 1.1 | GO:0071796 | K6-linked polyubiquitin binding(GO:0071796) |
| 0.3 | 1.1 | GO:0051435 | BH4 domain binding(GO:0051435) |
| 0.3 | 0.6 | GO:0048408 | epidermal growth factor binding(GO:0048408) |
| 0.3 | 0.8 | GO:0099580 | ion antiporter activity involved in regulation of postsynaptic membrane potential(GO:0099580) |
| 0.3 | 3.3 | GO:0008526 | phosphatidylinositol transporter activity(GO:0008526) |
| 0.3 | 0.8 | GO:0031896 | alpha-1A adrenergic receptor binding(GO:0031691) alpha-1B adrenergic receptor binding(GO:0031692) follicle-stimulating hormone receptor binding(GO:0031762) V2 vasopressin receptor binding(GO:0031896) |
| 0.3 | 2.5 | GO:0047134 | protein-disulfide reductase activity(GO:0047134) |
| 0.3 | 9.3 | GO:0004602 | glutathione peroxidase activity(GO:0004602) |
| 0.3 | 1.9 | GO:0005324 | long-chain fatty acid transporter activity(GO:0005324) |
| 0.3 | 6.3 | GO:0017049 | GTP-Rho binding(GO:0017049) |
| 0.3 | 1.6 | GO:0071532 | ankyrin repeat binding(GO:0071532) |
| 0.3 | 1.6 | GO:0004487 | methylenetetrahydrofolate dehydrogenase (NAD+) activity(GO:0004487) |
| 0.3 | 1.8 | GO:0004920 | interleukin-10 receptor activity(GO:0004920) |
| 0.3 | 3.0 | GO:0042809 | vitamin D receptor binding(GO:0042809) |
| 0.3 | 1.5 | GO:0061656 | SUMO conjugating enzyme activity(GO:0061656) |
| 0.2 | 14.7 | GO:0042379 | chemokine receptor binding(GO:0042379) |
| 0.2 | 1.0 | GO:0070740 | tubulin-glutamic acid ligase activity(GO:0070740) |
| 0.2 | 5.2 | GO:0051400 | BH domain binding(GO:0051400) |
| 0.2 | 3.5 | GO:0098641 | cadherin binding involved in cell-cell adhesion(GO:0098641) |
| 0.2 | 2.4 | GO:0016670 | oxidoreductase activity, acting on a sulfur group of donors, oxygen as acceptor(GO:0016670) |
| 0.2 | 4.8 | GO:0016290 | palmitoyl-CoA hydrolase activity(GO:0016290) |
| 0.2 | 1.7 | GO:0004016 | adenylate cyclase activity(GO:0004016) |
| 0.2 | 0.9 | GO:0031800 | type 3 metabotropic glutamate receptor binding(GO:0031800) |
| 0.2 | 2.8 | GO:0005176 | ErbB-2 class receptor binding(GO:0005176) |
| 0.2 | 2.5 | GO:0038062 | protein tyrosine kinase collagen receptor activity(GO:0038062) |
| 0.2 | 3.0 | GO:0008603 | cAMP-dependent protein kinase regulator activity(GO:0008603) |
| 0.2 | 0.7 | GO:0051916 | granulocyte colony-stimulating factor binding(GO:0051916) |
| 0.2 | 5.2 | GO:0001618 | virus receptor activity(GO:0001618) |
| 0.2 | 0.7 | GO:0017082 | mineralocorticoid receptor activity(GO:0017082) |
| 0.2 | 1.3 | GO:0010997 | anaphase-promoting complex binding(GO:0010997) |
| 0.2 | 1.8 | GO:0015349 | thyroid hormone transmembrane transporter activity(GO:0015349) |
| 0.2 | 1.5 | GO:0070180 | large ribosomal subunit rRNA binding(GO:0070180) |
| 0.2 | 10.5 | GO:0005164 | tumor necrosis factor receptor binding(GO:0005164) |
| 0.2 | 0.6 | GO:0003945 | N-acetyllactosamine synthase activity(GO:0003945) |
| 0.2 | 2.2 | GO:0001162 | RNA polymerase II intronic transcription regulatory region sequence-specific DNA binding(GO:0001162) |
| 0.2 | 0.6 | GO:0003896 | DNA primase activity(GO:0003896) |
| 0.2 | 1.3 | GO:0004692 | cGMP-dependent protein kinase activity(GO:0004692) |
| 0.2 | 2.3 | GO:0015217 | ATP transmembrane transporter activity(GO:0005347) ADP transmembrane transporter activity(GO:0015217) |
| 0.2 | 7.3 | GO:0070330 | aromatase activity(GO:0070330) |
| 0.2 | 1.6 | GO:0030274 | LIM domain binding(GO:0030274) |
| 0.2 | 2.0 | GO:0016618 | hydroxypyruvate reductase activity(GO:0016618) glyoxylate reductase (NADP) activity(GO:0030267) |
| 0.2 | 0.8 | GO:0019809 | spermidine binding(GO:0019809) |
| 0.2 | 2.2 | GO:0033691 | sialic acid binding(GO:0033691) |
| 0.2 | 2.6 | GO:0001069 | regulatory region RNA binding(GO:0001069) |
| 0.2 | 1.0 | GO:0005105 | type 1 fibroblast growth factor receptor binding(GO:0005105) |
| 0.2 | 1.4 | GO:0004865 | protein serine/threonine phosphatase inhibitor activity(GO:0004865) |
| 0.2 | 2.7 | GO:0004000 | adenosine deaminase activity(GO:0004000) |
| 0.2 | 2.9 | GO:0004385 | guanylate kinase activity(GO:0004385) |
| 0.2 | 1.6 | GO:0030235 | nitric-oxide synthase regulator activity(GO:0030235) |
| 0.2 | 1.5 | GO:0009378 | four-way junction helicase activity(GO:0009378) |
| 0.2 | 0.6 | GO:0035175 | histone kinase activity (H3-S10 specific)(GO:0035175) |
| 0.2 | 1.9 | GO:0030306 | ADP-ribosylation factor binding(GO:0030306) |
| 0.2 | 0.7 | GO:0008332 | low voltage-gated calcium channel activity(GO:0008332) |
| 0.2 | 4.0 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
| 0.2 | 0.9 | GO:0033130 | acetylcholine receptor binding(GO:0033130) |
| 0.2 | 1.8 | GO:0005030 | neurotrophin receptor activity(GO:0005030) |
| 0.2 | 2.5 | GO:0008097 | 5S rRNA binding(GO:0008097) |
| 0.2 | 6.1 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
| 0.2 | 1.6 | GO:0003873 | 6-phosphofructo-2-kinase activity(GO:0003873) |
| 0.2 | 1.5 | GO:0001968 | fibronectin binding(GO:0001968) |
| 0.2 | 8.0 | GO:0008373 | sialyltransferase activity(GO:0008373) |
| 0.2 | 3.7 | GO:0004435 | phosphatidylinositol phospholipase C activity(GO:0004435) |
| 0.2 | 8.4 | GO:0005518 | collagen binding(GO:0005518) |
| 0.2 | 3.2 | GO:0017160 | Ral GTPase binding(GO:0017160) |
| 0.2 | 0.5 | GO:0038100 | nodal binding(GO:0038100) |
| 0.2 | 1.0 | GO:0004656 | procollagen-proline 4-dioxygenase activity(GO:0004656) |
| 0.2 | 6.7 | GO:0005385 | zinc ion transmembrane transporter activity(GO:0005385) |
| 0.2 | 1.3 | GO:0008508 | bile acid:sodium symporter activity(GO:0008508) |
| 0.2 | 0.6 | GO:0031686 | A1 adenosine receptor binding(GO:0031686) |
| 0.2 | 1.9 | GO:0015269 | calcium-activated potassium channel activity(GO:0015269) |
| 0.2 | 0.5 | GO:0030618 | transforming growth factor beta receptor, pathway-specific cytoplasmic mediator activity(GO:0030618) |
| 0.2 | 1.8 | GO:0048531 | beta-1,3-galactosyltransferase activity(GO:0048531) |
| 0.2 | 1.1 | GO:0015450 | P-P-bond-hydrolysis-driven protein transmembrane transporter activity(GO:0015450) |
| 0.2 | 0.6 | GO:0016230 | sphingomyelin phosphodiesterase activator activity(GO:0016230) |
| 0.2 | 35.1 | GO:0004252 | serine-type endopeptidase activity(GO:0004252) |
| 0.1 | 1.8 | GO:0036374 | glutathione hydrolase activity(GO:0036374) |
| 0.1 | 4.7 | GO:0005201 | extracellular matrix structural constituent(GO:0005201) |
| 0.1 | 1.2 | GO:0043325 | phosphatidylinositol-3,4-bisphosphate binding(GO:0043325) |
| 0.1 | 2.0 | GO:0017176 | phosphatidylinositol N-acetylglucosaminyltransferase activity(GO:0017176) |
| 0.1 | 2.1 | GO:0035612 | AP-2 adaptor complex binding(GO:0035612) |
| 0.1 | 1.1 | GO:0071933 | Arp2/3 complex binding(GO:0071933) |
| 0.1 | 2.4 | GO:0003796 | lysozyme activity(GO:0003796) |
| 0.1 | 7.0 | GO:0004683 | calmodulin-dependent protein kinase activity(GO:0004683) |
| 0.1 | 0.4 | GO:0042289 | MHC class II protein binding(GO:0042289) |
| 0.1 | 0.4 | GO:0004694 | eukaryotic translation initiation factor 2alpha kinase activity(GO:0004694) |
| 0.1 | 0.3 | GO:0097677 | STAT family protein binding(GO:0097677) |
| 0.1 | 1.6 | GO:0019855 | calcium channel inhibitor activity(GO:0019855) |
| 0.1 | 4.2 | GO:0005112 | Notch binding(GO:0005112) |
| 0.1 | 1.3 | GO:0043495 | protein anchor(GO:0043495) |
| 0.1 | 1.4 | GO:0008020 | G-protein coupled photoreceptor activity(GO:0008020) |
| 0.1 | 1.2 | GO:0061676 | importin-alpha family protein binding(GO:0061676) |
| 0.1 | 1.7 | GO:0000400 | four-way junction DNA binding(GO:0000400) |
| 0.1 | 0.5 | GO:0019970 | interleukin-11 receptor activity(GO:0004921) interleukin-11 binding(GO:0019970) |
| 0.1 | 2.1 | GO:0017017 | MAP kinase tyrosine/serine/threonine phosphatase activity(GO:0017017) |
| 0.1 | 1.1 | GO:0008479 | queuine tRNA-ribosyltransferase activity(GO:0008479) |
| 0.1 | 0.7 | GO:0030942 | endoplasmic reticulum signal peptide binding(GO:0030942) |
| 0.1 | 5.7 | GO:0004864 | protein phosphatase inhibitor activity(GO:0004864) |
| 0.1 | 2.6 | GO:0070273 | phosphatidylinositol-4-phosphate binding(GO:0070273) |
| 0.1 | 0.4 | GO:0035256 | G-protein coupled glutamate receptor binding(GO:0035256) |
| 0.1 | 3.0 | GO:0003746 | translation elongation factor activity(GO:0003746) |
| 0.1 | 6.2 | GO:0019843 | rRNA binding(GO:0019843) |
| 0.1 | 6.8 | GO:0035035 | histone acetyltransferase binding(GO:0035035) |
| 0.1 | 1.9 | GO:0042608 | T cell receptor binding(GO:0042608) |
| 0.1 | 1.0 | GO:0000774 | adenyl-nucleotide exchange factor activity(GO:0000774) |
| 0.1 | 2.4 | GO:0023026 | MHC class II protein complex binding(GO:0023026) |
| 0.1 | 2.8 | GO:0017075 | syntaxin-1 binding(GO:0017075) |
| 0.1 | 0.3 | GO:0005169 | neurotrophin TRKB receptor binding(GO:0005169) |
| 0.1 | 5.1 | GO:0001965 | G-protein alpha-subunit binding(GO:0001965) |
| 0.1 | 0.8 | GO:0008379 | thioredoxin peroxidase activity(GO:0008379) |
| 0.1 | 2.2 | GO:0030296 | protein tyrosine kinase activator activity(GO:0030296) |
| 0.1 | 1.0 | GO:0017050 | sphinganine kinase activity(GO:0008481) D-erythro-sphingosine kinase activity(GO:0017050) |
| 0.1 | 2.4 | GO:0050811 | GABA receptor binding(GO:0050811) |
| 0.1 | 0.4 | GO:0042978 | ornithine decarboxylase activator activity(GO:0042978) |
| 0.1 | 3.6 | GO:0005184 | neuropeptide hormone activity(GO:0005184) |
| 0.1 | 1.2 | GO:0050815 | phosphoserine binding(GO:0050815) |
| 0.1 | 2.4 | GO:0070300 | phosphatidic acid binding(GO:0070300) |
| 0.1 | 1.2 | GO:0048273 | mitogen-activated protein kinase p38 binding(GO:0048273) |
| 0.1 | 1.5 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
| 0.1 | 1.3 | GO:0016783 | sulfurtransferase activity(GO:0016783) |
| 0.1 | 0.3 | GO:0033149 | FFAT motif binding(GO:0033149) |
| 0.1 | 0.3 | GO:0052692 | raffinose alpha-galactosidase activity(GO:0052692) |
| 0.1 | 3.7 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
| 0.1 | 0.3 | GO:0003923 | GPI-anchor transamidase activity(GO:0003923) |
| 0.1 | 28.5 | GO:0045296 | cadherin binding(GO:0045296) |
| 0.1 | 4.1 | GO:1990841 | promoter-specific chromatin binding(GO:1990841) |
| 0.1 | 0.3 | GO:0008048 | calcium sensitive guanylate cyclase activator activity(GO:0008048) |
| 0.1 | 0.4 | GO:0008494 | translation activator activity(GO:0008494) |
| 0.1 | 59.8 | GO:0005198 | structural molecule activity(GO:0005198) |
| 0.1 | 1.1 | GO:0047391 | alkylglycerophosphoethanolamine phosphodiesterase activity(GO:0047391) |
| 0.1 | 2.2 | GO:0005248 | voltage-gated sodium channel activity(GO:0005248) |
| 0.1 | 2.6 | GO:0008378 | galactosyltransferase activity(GO:0008378) |
| 0.1 | 0.5 | GO:0072345 | NAADP-sensitive calcium-release channel activity(GO:0072345) |
| 0.1 | 3.1 | GO:0042805 | actinin binding(GO:0042805) |
| 0.1 | 0.7 | GO:0052851 | cupric reductase activity(GO:0008823) ferric-chelate reductase (NADPH) activity(GO:0052851) |
| 0.1 | 0.4 | GO:0016499 | orexin receptor activity(GO:0016499) |
| 0.1 | 0.8 | GO:0070016 | armadillo repeat domain binding(GO:0070016) |
| 0.1 | 0.5 | GO:0015086 | cadmium ion transmembrane transporter activity(GO:0015086) cobalt ion transmembrane transporter activity(GO:0015087) lead ion transmembrane transporter activity(GO:0015094) nickel cation transmembrane transporter activity(GO:0015099) vanadium ion transmembrane transporter activity(GO:0015100) ferrous iron uptake transmembrane transporter activity(GO:0015639) |
| 0.1 | 1.0 | GO:0008656 | cysteine-type endopeptidase activator activity involved in apoptotic process(GO:0008656) |
| 0.1 | 0.2 | GO:0001847 | opsonin receptor activity(GO:0001847) |
| 0.1 | 1.4 | GO:0036312 | phosphatidylinositol 3-kinase regulatory subunit binding(GO:0036312) |
| 0.1 | 1.9 | GO:0016805 | dipeptidase activity(GO:0016805) |
| 0.1 | 7.1 | GO:0004536 | deoxyribonuclease activity(GO:0004536) |
| 0.1 | 0.6 | GO:0010521 | telomerase inhibitor activity(GO:0010521) |
| 0.1 | 1.4 | GO:0031683 | G-protein beta/gamma-subunit complex binding(GO:0031683) |
| 0.1 | 0.4 | GO:0019767 | IgE receptor activity(GO:0019767) |
| 0.1 | 0.2 | GO:0042602 | riboflavin reductase (NADPH) activity(GO:0042602) |
| 0.1 | 1.6 | GO:0035259 | glucocorticoid receptor binding(GO:0035259) |
| 0.1 | 0.8 | GO:0051010 | microtubule plus-end binding(GO:0051010) |
| 0.1 | 1.6 | GO:0043014 | alpha-tubulin binding(GO:0043014) |
| 0.1 | 0.3 | GO:0035827 | rubidium ion transmembrane transporter activity(GO:0035827) |
| 0.1 | 3.2 | GO:0005547 | phosphatidylinositol-3,4,5-trisphosphate binding(GO:0005547) |
| 0.1 | 2.8 | GO:0050699 | WW domain binding(GO:0050699) |
| 0.1 | 0.2 | GO:0008073 | ornithine decarboxylase inhibitor activity(GO:0008073) ornithine decarboxylase regulator activity(GO:0042979) |
| 0.1 | 0.9 | GO:0005388 | calcium-transporting ATPase activity(GO:0005388) |
| 0.1 | 1.9 | GO:0071889 | 14-3-3 protein binding(GO:0071889) |
| 0.1 | 9.6 | GO:0005089 | Rho guanyl-nucleotide exchange factor activity(GO:0005089) |
| 0.1 | 0.4 | GO:0086089 | voltage-gated potassium channel activity involved in atrial cardiac muscle cell action potential repolarization(GO:0086089) |
| 0.1 | 21.4 | GO:0015631 | tubulin binding(GO:0015631) |
| 0.1 | 1.6 | GO:0015026 | coreceptor activity(GO:0015026) |
| 0.1 | 0.4 | GO:0008568 | microtubule-severing ATPase activity(GO:0008568) |
| 0.1 | 2.6 | GO:0043027 | cysteine-type endopeptidase inhibitor activity involved in apoptotic process(GO:0043027) |
| 0.1 | 0.6 | GO:0016175 | superoxide-generating NADPH oxidase activity(GO:0016175) |
| 0.1 | 0.7 | GO:0016813 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines(GO:0016813) |
| 0.1 | 37.5 | GO:0005509 | calcium ion binding(GO:0005509) |
| 0.1 | 0.3 | GO:0070139 | ubiquitin-like protein-specific endopeptidase activity(GO:0070137) SUMO-specific endopeptidase activity(GO:0070139) |
| 0.1 | 0.2 | GO:0042282 | hydroxymethylglutaryl-CoA reductase (NADPH) activity(GO:0004420) hydroxymethylglutaryl-CoA reductase activity(GO:0042282) |
| 0.1 | 0.6 | GO:0030550 | acetylcholine receptor inhibitor activity(GO:0030550) |
| 0.1 | 0.5 | GO:0061578 | Lys63-specific deubiquitinase activity(GO:0061578) |
| 0.1 | 0.7 | GO:0001135 | transcription factor activity, RNA polymerase II transcription factor recruiting(GO:0001135) |
| 0.1 | 9.6 | GO:0017137 | Rab GTPase binding(GO:0017137) |
| 0.1 | 0.5 | GO:0098821 | BMP receptor activity(GO:0098821) |
| 0.1 | 0.6 | GO:0004143 | diacylglycerol kinase activity(GO:0004143) |
| 0.1 | 0.2 | GO:0035800 | deubiquitinase activator activity(GO:0035800) |
| 0.1 | 7.4 | GO:0034987 | immunoglobulin receptor binding(GO:0034987) |
| 0.1 | 0.5 | GO:0005041 | low-density lipoprotein receptor activity(GO:0005041) |
| 0.1 | 0.2 | GO:0003963 | RNA-3'-phosphate cyclase activity(GO:0003963) |
| 0.1 | 1.2 | GO:0043274 | phospholipase binding(GO:0043274) |
| 0.1 | 0.2 | GO:0004430 | 1-phosphatidylinositol 4-kinase activity(GO:0004430) |
| 0.1 | 0.1 | GO:0005519 | cytoskeletal regulatory protein binding(GO:0005519) |
| 0.1 | 2.7 | GO:0017080 | sodium channel regulator activity(GO:0017080) |
| 0.1 | 2.2 | GO:0008236 | serine-type peptidase activity(GO:0008236) |
| 0.1 | 0.4 | GO:0043138 | 3'-5' DNA helicase activity(GO:0043138) |
| 0.1 | 0.4 | GO:0034236 | protein kinase A catalytic subunit binding(GO:0034236) |
| 0.1 | 0.5 | GO:0005127 | ciliary neurotrophic factor receptor binding(GO:0005127) |
| 0.1 | 1.3 | GO:0070006 | metalloaminopeptidase activity(GO:0070006) |
| 0.1 | 0.3 | GO:0004985 | opioid receptor activity(GO:0004985) |
| 0.1 | 0.9 | GO:0005537 | mannose binding(GO:0005537) |
| 0.1 | 0.9 | GO:0045028 | G-protein coupled nucleotide receptor activity(GO:0001608) G-protein coupled purinergic nucleotide receptor activity(GO:0045028) |
| 0.1 | 1.2 | GO:0005355 | glucose transmembrane transporter activity(GO:0005355) hexose transmembrane transporter activity(GO:0015149) |
| 0.1 | 4.7 | GO:0004896 | cytokine receptor activity(GO:0004896) |
| 0.1 | 0.4 | GO:0048185 | activin binding(GO:0048185) |
| 0.0 | 0.2 | GO:0015440 | peptide-transporting ATPase activity(GO:0015440) |
| 0.0 | 1.6 | GO:0046875 | ephrin receptor binding(GO:0046875) |
| 0.0 | 0.1 | GO:0051021 | GDP-dissociation inhibitor binding(GO:0051021) |
| 0.0 | 1.1 | GO:0071837 | HMG box domain binding(GO:0071837) |
| 0.0 | 0.1 | GO:0050510 | N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity(GO:0050510) |
| 0.0 | 0.2 | GO:0046912 | transferase activity, transferring acyl groups, acyl groups converted into alkyl on transfer(GO:0046912) |
| 0.0 | 4.0 | GO:0003730 | mRNA 3'-UTR binding(GO:0003730) |
| 0.0 | 0.9 | GO:0035198 | miRNA binding(GO:0035198) |
| 0.0 | 0.2 | GO:0031435 | mitogen-activated protein kinase kinase kinase binding(GO:0031435) |
| 0.0 | 0.7 | GO:0003688 | DNA replication origin binding(GO:0003688) |
| 0.0 | 0.4 | GO:0005007 | fibroblast growth factor-activated receptor activity(GO:0005007) |
| 0.0 | 0.2 | GO:0016936 | galactoside binding(GO:0016936) |
| 0.0 | 0.3 | GO:0004576 | oligosaccharyl transferase activity(GO:0004576) dolichyl-diphosphooligosaccharide-protein glycotransferase activity(GO:0004579) |
| 0.0 | 0.2 | GO:0035197 | siRNA binding(GO:0035197) |
| 0.0 | 0.4 | GO:0004445 | inositol-polyphosphate 5-phosphatase activity(GO:0004445) inositol trisphosphate phosphatase activity(GO:0046030) |
| 0.0 | 0.2 | GO:0004966 | galanin receptor activity(GO:0004966) |
| 0.0 | 1.6 | GO:0003899 | DNA-directed RNA polymerase activity(GO:0003899) |
| 0.0 | 1.0 | GO:0005149 | interleukin-1 receptor binding(GO:0005149) |
| 0.0 | 9.0 | GO:0001078 | transcriptional repressor activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001078) |
| 0.0 | 0.4 | GO:0031386 | protein tag(GO:0031386) |
| 0.0 | 0.8 | GO:0022840 | leak channel activity(GO:0022840) narrow pore channel activity(GO:0022842) |
| 0.0 | 0.6 | GO:0035255 | ionotropic glutamate receptor binding(GO:0035255) |
| 0.0 | 0.6 | GO:0030546 | receptor activator activity(GO:0030546) |
| 0.0 | 0.3 | GO:1990226 | histone methyltransferase binding(GO:1990226) |
| 0.0 | 1.1 | GO:0004407 | histone deacetylase activity(GO:0004407) |
| 0.0 | 0.2 | GO:0004035 | alkaline phosphatase activity(GO:0004035) |
| 0.0 | 2.4 | GO:0031490 | chromatin DNA binding(GO:0031490) |
| 0.0 | 0.6 | GO:0035174 | histone serine kinase activity(GO:0035174) |
| 0.0 | 0.1 | GO:0036310 | annealing helicase activity(GO:0036310) |
| 0.0 | 0.5 | GO:0046933 | proton-transporting ATP synthase activity, rotational mechanism(GO:0046933) |
| 0.0 | 0.2 | GO:0019784 | NEDD8-specific protease activity(GO:0019784) |
| 0.0 | 0.5 | GO:0005351 | sugar:proton symporter activity(GO:0005351) cation:sugar symporter activity(GO:0005402) |
| 0.0 | 2.3 | GO:0005178 | integrin binding(GO:0005178) |
| 0.0 | 0.2 | GO:0070097 | delta-catenin binding(GO:0070097) |
| 0.0 | 0.8 | GO:0044183 | protein binding involved in protein folding(GO:0044183) |
| 0.0 | 2.9 | GO:0017124 | SH3 domain binding(GO:0017124) |
| 0.0 | 0.2 | GO:0038036 | sphingosine-1-phosphate receptor activity(GO:0038036) |
| 0.0 | 0.7 | GO:0070577 | lysine-acetylated histone binding(GO:0070577) |
| 0.0 | 0.8 | GO:0019707 | protein-cysteine S-palmitoyltransferase activity(GO:0019706) protein-cysteine S-acyltransferase activity(GO:0019707) |
| 0.0 | 4.4 | GO:0008022 | protein C-terminus binding(GO:0008022) |
| 0.0 | 0.3 | GO:0003956 | NAD(P)+-protein-arginine ADP-ribosyltransferase activity(GO:0003956) |
| 0.0 | 0.5 | GO:0001784 | phosphotyrosine binding(GO:0001784) |
| 0.0 | 0.6 | GO:0017022 | myosin binding(GO:0017022) |
| 0.0 | 0.7 | GO:0019239 | deaminase activity(GO:0019239) |
| 0.0 | 0.3 | GO:0015035 | protein disulfide oxidoreductase activity(GO:0015035) |
| 0.0 | 0.1 | GO:0019870 | potassium channel inhibitor activity(GO:0019870) |
| 0.0 | 0.4 | GO:0031491 | nucleosome binding(GO:0031491) |
| 0.0 | 0.0 | GO:0033592 | RNA strand annealing activity(GO:0033592) |
| 0.0 | 2.2 | GO:0008083 | growth factor activity(GO:0008083) |
| 0.0 | 0.2 | GO:0001075 | transcription factor activity, RNA polymerase II core promoter sequence-specific binding involved in preinitiation complex assembly(GO:0001075) |
| 0.0 | 0.1 | GO:0038181 | bile acid receptor activity(GO:0038181) |
| 0.0 | 0.5 | GO:0043425 | bHLH transcription factor binding(GO:0043425) |
| 0.0 | 1.9 | GO:0044325 | ion channel binding(GO:0044325) |
| 0.0 | 0.2 | GO:0034237 | protein kinase A regulatory subunit binding(GO:0034237) |
| 0.0 | 0.2 | GO:0000983 | transcription factor activity, RNA polymerase II core promoter sequence-specific(GO:0000983) |
| 0.0 | 0.2 | GO:0004565 | beta-galactosidase activity(GO:0004565) |
| 0.0 | 0.2 | GO:0070182 | DNA polymerase binding(GO:0070182) |
| 0.0 | 0.3 | GO:0070003 | threonine-type endopeptidase activity(GO:0004298) threonine-type peptidase activity(GO:0070003) |
| 0.0 | 0.2 | GO:0031957 | very long-chain fatty acid-CoA ligase activity(GO:0031957) |
| 0.0 | 1.1 | GO:0005262 | calcium channel activity(GO:0005262) |
| 0.0 | 1.0 | GO:0035064 | methylated histone binding(GO:0035064) |
| 0.0 | 0.3 | GO:0042171 | lysophosphatidic acid acyltransferase activity(GO:0042171) |
| 0.0 | 0.1 | GO:0004080 | biotin-[acetyl-CoA-carboxylase] ligase activity(GO:0004077) biotin-[methylcrotonoyl-CoA-carboxylase] ligase activity(GO:0004078) biotin-[methylmalonyl-CoA-carboxytransferase] ligase activity(GO:0004079) biotin-[propionyl-CoA-carboxylase (ATP-hydrolyzing)] ligase activity(GO:0004080) biotin-protein ligase activity(GO:0018271) |
| 0.0 | 0.1 | GO:0004711 | ribosomal protein S6 kinase activity(GO:0004711) |
| 0.0 | 0.1 | GO:0042288 | MHC class I protein binding(GO:0042288) |
| 0.0 | 0.0 | GO:0047057 | oxidoreductase activity, acting on the CH-OH group of donors, disulfide as acceptor(GO:0016900) vitamin-K-epoxide reductase (warfarin-sensitive) activity(GO:0047057) |
Gene overrepresentation in curated gene sets: canonical pathways category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 1.2 | 1.2 | PID NFKAPPAB CANONICAL PATHWAY | Canonical NF-kappaB pathway |
| 0.9 | 20.8 | PID S1P S1P4 PATHWAY | S1P4 pathway |
| 0.7 | 21.0 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
| 0.6 | 5.5 | ST PAC1 RECEPTOR PATHWAY | PAC1 Receptor Pathway |
| 0.6 | 10.3 | PID INTEGRIN4 PATHWAY | Alpha6 beta4 integrin-ligand interactions |
| 0.6 | 20.3 | PID INSULIN GLUCOSE PATHWAY | Insulin-mediated glucose transport |
| 0.5 | 29.0 | PID WNT NONCANONICAL PATHWAY | Noncanonical Wnt signaling pathway |
| 0.5 | 6.0 | ST INTERFERON GAMMA PATHWAY | Interferon gamma pathway. |
| 0.5 | 100.1 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
| 0.5 | 20.6 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
| 0.5 | 14.5 | PID NECTIN PATHWAY | Nectin adhesion pathway |
| 0.4 | 32.7 | PID P38 ALPHA BETA DOWNSTREAM PATHWAY | Signaling mediated by p38-alpha and p38-beta |
| 0.4 | 15.6 | PID NCADHERIN PATHWAY | N-cadherin signaling events |
| 0.4 | 24.5 | PID SYNDECAN 1 PATHWAY | Syndecan-1-mediated signaling events |
| 0.4 | 10.4 | ST GA12 PATHWAY | G alpha 12 Pathway |
| 0.4 | 12.0 | PID SYNDECAN 2 PATHWAY | Syndecan-2-mediated signaling events |
| 0.4 | 8.5 | SA B CELL RECEPTOR COMPLEXES | Antigen binding to B cell receptors activates protein tyrosine kinases, such as the Src family, which ultimate activate MAP kinases. |
| 0.4 | 6.2 | PID THROMBIN PAR4 PATHWAY | PAR4-mediated thrombin signaling events |
| 0.3 | 9.1 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
| 0.3 | 17.5 | PID ECADHERIN STABILIZATION PATHWAY | Stabilization and expansion of the E-cadherin adherens junction |
| 0.3 | 22.9 | PID TAP63 PATHWAY | Validated transcriptional targets of TAp63 isoforms |
| 0.3 | 8.2 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
| 0.3 | 12.0 | SIG PIP3 SIGNALING IN B LYMPHOCYTES | Genes related to PIP3 signaling in B lymphocytes |
| 0.3 | 6.0 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
| 0.3 | 3.7 | ST PHOSPHOINOSITIDE 3 KINASE PATHWAY | PI3K Pathway |
| 0.3 | 13.2 | PID IL23 PATHWAY | IL23-mediated signaling events |
| 0.3 | 2.9 | PID AVB3 OPN PATHWAY | Osteopontin-mediated events |
| 0.3 | 5.8 | SA PROGRAMMED CELL DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
| 0.3 | 2.1 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
| 0.3 | 8.0 | PID RET PATHWAY | Signaling events regulated by Ret tyrosine kinase |
| 0.3 | 15.9 | PID ILK PATHWAY | Integrin-linked kinase signaling |
| 0.3 | 4.5 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
| 0.2 | 5.3 | PID IL3 PATHWAY | IL3-mediated signaling events |
| 0.2 | 12.6 | SIG REGULATION OF THE ACTIN CYTOSKELETON BY RHO GTPASES | Genes related to regulation of the actin cytoskeleton |
| 0.2 | 5.1 | PID ARF6 PATHWAY | Arf6 signaling events |
| 0.2 | 8.4 | PID PTP1B PATHWAY | Signaling events mediated by PTP1B |
| 0.2 | 13.1 | PID CERAMIDE PATHWAY | Ceramide signaling pathway |
| 0.2 | 5.0 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
| 0.2 | 1.3 | PID GMCSF PATHWAY | GMCSF-mediated signaling events |
| 0.2 | 21.3 | PID NOTCH PATHWAY | Notch signaling pathway |
| 0.2 | 2.1 | PID INTEGRIN A9B1 PATHWAY | Alpha9 beta1 integrin signaling events |
| 0.2 | 67.3 | NABA SECRETED FACTORS | Genes encoding secreted soluble factors |
| 0.2 | 6.1 | PID ATF2 PATHWAY | ATF-2 transcription factor network |
| 0.2 | 4.2 | PID PS1 PATHWAY | Presenilin action in Notch and Wnt signaling |
| 0.2 | 2.2 | PID FAK PATHWAY | Signaling events mediated by focal adhesion kinase |
| 0.2 | 1.7 | PID S1P S1P1 PATHWAY | S1P1 pathway |
| 0.2 | 1.1 | PID AMB2 NEUTROPHILS PATHWAY | amb2 Integrin signaling |
| 0.2 | 2.0 | PID ERBB2 ERBB3 PATHWAY | ErbB2/ErbB3 signaling events |
| 0.2 | 3.8 | PID EPHA FWDPATHWAY | EPHA forward signaling |
| 0.2 | 3.6 | PID SMAD2 3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
| 0.2 | 4.8 | PID AJDISS 2PATHWAY | Posttranslational regulation of adherens junction stability and dissassembly |
| 0.2 | 16.6 | PID RHOA REG PATHWAY | Regulation of RhoA activity |
| 0.2 | 0.8 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
| 0.2 | 2.5 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
| 0.2 | 13.3 | PID HIF1 TFPATHWAY | HIF-1-alpha transcription factor network |
| 0.2 | 42.3 | NABA MATRISOME ASSOCIATED | Ensemble of genes encoding ECM-associated proteins including ECM-affilaited proteins, ECM regulators and secreted factors |
| 0.2 | 6.9 | PID IL4 2PATHWAY | IL4-mediated signaling events |
| 0.2 | 5.5 | PID ARF6 TRAFFICKING PATHWAY | Arf6 trafficking events |
| 0.2 | 0.9 | PID BARD1 PATHWAY | BARD1 signaling events |
| 0.1 | 3.9 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
| 0.1 | 7.1 | PID CASPASE PATHWAY | Caspase cascade in apoptosis |
| 0.1 | 2.2 | PID INTEGRIN3 PATHWAY | Beta3 integrin cell surface interactions |
| 0.1 | 2.3 | PID IL12 STAT4 PATHWAY | IL12 signaling mediated by STAT4 |
| 0.1 | 2.1 | PID MAPK TRK PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
| 0.1 | 2.9 | PID FOXM1 PATHWAY | FOXM1 transcription factor network |
| 0.1 | 4.5 | PID RAS PATHWAY | Regulation of Ras family activation |
| 0.1 | 2.0 | PID ENDOTHELIN PATHWAY | Endothelins |
| 0.1 | 8.0 | PID PDGFRB PATHWAY | PDGFR-beta signaling pathway |
| 0.1 | 1.6 | PID CXCR4 PATHWAY | CXCR4-mediated signaling events |
| 0.1 | 2.5 | PID FCER1 PATHWAY | Fc-epsilon receptor I signaling in mast cells |
| 0.1 | 7.8 | PID BETA CATENIN NUC PATHWAY | Regulation of nuclear beta catenin signaling and target gene transcription |
| 0.1 | 3.4 | PID ERBB1 DOWNSTREAM PATHWAY | ErbB1 downstream signaling |
| 0.1 | 0.7 | PID TCR JNK PATHWAY | JNK signaling in the CD4+ TCR pathway |
| 0.1 | 0.4 | PID THROMBIN PAR1 PATHWAY | PAR1-mediated thrombin signaling events |
| 0.1 | 2.4 | ST INTEGRIN SIGNALING PATHWAY | Integrin Signaling Pathway |
| 0.1 | 1.7 | PID IL12 2PATHWAY | IL12-mediated signaling events |
| 0.1 | 2.0 | ST TUMOR NECROSIS FACTOR PATHWAY | Tumor Necrosis Factor Pathway. |
| 0.1 | 1.5 | PID RAC1 PATHWAY | RAC1 signaling pathway |
| 0.1 | 2.6 | PID FOXO PATHWAY | FoxO family signaling |
| 0.1 | 4.1 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
| 0.1 | 2.3 | PID AURORA B PATHWAY | Aurora B signaling |
| 0.1 | 0.5 | PID ERBB4 PATHWAY | ErbB4 signaling events |
| 0.1 | 1.3 | PID ALPHA SYNUCLEIN PATHWAY | Alpha-synuclein signaling |
| 0.1 | 2.0 | PID ATR PATHWAY | ATR signaling pathway |
| 0.1 | 4.2 | WNT SIGNALING | Genes related to Wnt-mediated signal transduction |
| 0.1 | 10.3 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
| 0.1 | 3.8 | PID ERA GENOMIC PATHWAY | Validated nuclear estrogen receptor alpha network |
| 0.1 | 2.3 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
| 0.1 | 0.5 | PID CD8 TCR PATHWAY | TCR signaling in naïve CD8+ T cells |
| 0.1 | 0.8 | PID AURORA A PATHWAY | Aurora A signaling |
| 0.1 | 0.4 | SIG BCR SIGNALING PATHWAY | Members of the BCR signaling pathway |
| 0.1 | 3.7 | PID AR PATHWAY | Coregulation of Androgen receptor activity |
| 0.0 | 0.4 | PID HIF1A PATHWAY | Hypoxic and oxygen homeostasis regulation of HIF-1-alpha |
| 0.0 | 0.3 | PID FGF PATHWAY | FGF signaling pathway |
| 0.0 | 0.2 | PID CIRCADIAN PATHWAY | Circadian rhythm pathway |
| 0.0 | 0.2 | PID TNF PATHWAY | TNF receptor signaling pathway |
| 0.0 | 0.1 | PID ALK2 PATHWAY | ALK2 signaling events |
| 0.0 | 0.2 | SIG INSULIN RECEPTOR PATHWAY IN CARDIAC MYOCYTES | Genes related to the insulin receptor pathway |
| 0.0 | 0.4 | PID P53 REGULATION PATHWAY | p53 pathway |
| 0.0 | 0.3 | PID RHODOPSIN PATHWAY | Visual signal transduction: Rods |
Gene overrepresentation in curated gene sets: REACTOME pathways category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 0.8 | 21.9 | REACTOME TERMINATION OF O GLYCAN BIOSYNTHESIS | Genes involved in Termination of O-glycan biosynthesis |
| 0.8 | 12.3 | REACTOME RNA POL I PROMOTER OPENING | Genes involved in RNA Polymerase I Promoter Opening |
| 0.7 | 19.0 | REACTOME ACYL CHAIN REMODELLING OF PC | Genes involved in Acyl chain remodelling of PC |
| 0.6 | 8.6 | REACTOME CS DS DEGRADATION | Genes involved in CS/DS degradation |
| 0.6 | 37.8 | REACTOME STRIATED MUSCLE CONTRACTION | Genes involved in Striated Muscle Contraction |
| 0.6 | 5.6 | REACTOME PROSTANOID LIGAND RECEPTORS | Genes involved in Prostanoid ligand receptors |
| 0.5 | 3.8 | REACTOME REGULATION OF INSULIN SECRETION BY ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
| 0.5 | 5.4 | REACTOME ELEVATION OF CYTOSOLIC CA2 LEVELS | Genes involved in Elevation of cytosolic Ca2+ levels |
| 0.5 | 12.0 | REACTOME PYRUVATE METABOLISM | Genes involved in Pyruvate metabolism |
| 0.5 | 0.5 | REACTOME NEF MEDIATES DOWN MODULATION OF CELL SURFACE RECEPTORS BY RECRUITING THEM TO CLATHRIN ADAPTERS | Genes involved in Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters |
| 0.4 | 13.4 | REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
| 0.4 | 9.1 | REACTOME ADENYLATE CYCLASE INHIBITORY PATHWAY | Genes involved in Adenylate cyclase inhibitory pathway |
| 0.4 | 1.3 | REACTOME OLFACTORY SIGNALING PATHWAY | Genes involved in Olfactory Signaling Pathway |
| 0.4 | 30.1 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
| 0.4 | 1.3 | REACTOME SHC1 EVENTS IN ERBB4 SIGNALING | Genes involved in SHC1 events in ERBB4 signaling |
| 0.4 | 16.8 | REACTOME GLYCOSPHINGOLIPID METABOLISM | Genes involved in Glycosphingolipid metabolism |
| 0.4 | 8.2 | REACTOME HS GAG DEGRADATION | Genes involved in HS-GAG degradation |
| 0.4 | 17.4 | REACTOME RECYCLING PATHWAY OF L1 | Genes involved in Recycling pathway of L1 |
| 0.4 | 14.7 | REACTOME GRB2 EVENTS IN ERBB2 SIGNALING | Genes involved in GRB2 events in ERBB2 signaling |
| 0.4 | 5.9 | REACTOME THE NLRP3 INFLAMMASOME | Genes involved in The NLRP3 inflammasome |
| 0.4 | 3.2 | REACTOME PLATELET ADHESION TO EXPOSED COLLAGEN | Genes involved in Platelet Adhesion to exposed collagen |
| 0.3 | 12.9 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
| 0.3 | 7.6 | REACTOME SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN | Genes involved in Synthesis, Secretion, and Deacylation of Ghrelin |
| 0.3 | 15.5 | REACTOME PLC BETA MEDIATED EVENTS | Genes involved in PLC beta mediated events |
| 0.3 | 12.2 | REACTOME BASIGIN INTERACTIONS | Genes involved in Basigin interactions |
| 0.3 | 3.5 | REACTOME APOPTOSIS INDUCED DNA FRAGMENTATION | Genes involved in Apoptosis induced DNA fragmentation |
| 0.3 | 2.2 | REACTOME HYALURONAN UPTAKE AND DEGRADATION | Genes involved in Hyaluronan uptake and degradation |
| 0.3 | 2.5 | REACTOME COMMON PATHWAY | Genes involved in Common Pathway |
| 0.3 | 3.7 | REACTOME G2 M DNA DAMAGE CHECKPOINT | Genes involved in G2/M DNA damage checkpoint |
| 0.3 | 6.6 | REACTOME APOPTOTIC CLEAVAGE OF CELL ADHESION PROTEINS | Genes involved in Apoptotic cleavage of cell adhesion proteins |
| 0.3 | 6.5 | REACTOME REGULATION OF SIGNALING BY CBL | Genes involved in Regulation of signaling by CBL |
| 0.3 | 1.4 | REACTOME REGULATION OF KIT SIGNALING | Genes involved in Regulation of KIT signaling |
| 0.3 | 3.8 | REACTOME PASSIVE TRANSPORT BY AQUAPORINS | Genes involved in Passive Transport by Aquaporins |
| 0.3 | 1.9 | REACTOME REGULATION OF WATER BALANCE BY RENAL AQUAPORINS | Genes involved in Regulation of Water Balance by Renal Aquaporins |
| 0.3 | 3.7 | REACTOME REGULATION OF COMPLEMENT CASCADE | Genes involved in Regulation of Complement cascade |
| 0.3 | 7.7 | REACTOME SYNTHESIS OF PA | Genes involved in Synthesis of PA |
| 0.2 | 5.4 | REACTOME CRMPS IN SEMA3A SIGNALING | Genes involved in CRMPs in Sema3A signaling |
| 0.2 | 22.8 | REACTOME CELL JUNCTION ORGANIZATION | Genes involved in Cell junction organization |
| 0.2 | 3.3 | REACTOME CHONDROITIN SULFATE BIOSYNTHESIS | Genes involved in Chondroitin sulfate biosynthesis |
| 0.2 | 13.5 | REACTOME INTERFERON ALPHA BETA SIGNALING | Genes involved in Interferon alpha/beta signaling |
| 0.2 | 5.6 | REACTOME PURINE SALVAGE | Genes involved in Purine salvage |
| 0.2 | 5.8 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
| 0.2 | 2.6 | REACTOME RECEPTOR LIGAND BINDING INITIATES THE SECOND PROTEOLYTIC CLEAVAGE OF NOTCH RECEPTOR | Genes involved in Receptor-ligand binding initiates the second proteolytic cleavage of Notch receptor |
| 0.2 | 7.2 | REACTOME SYNTHESIS OF PC | Genes involved in Synthesis of PC |
| 0.2 | 10.3 | REACTOME LATENT INFECTION OF HOMO SAPIENS WITH MYCOBACTERIUM TUBERCULOSIS | Genes involved in Latent infection of Homo sapiens with Mycobacterium tuberculosis |
| 0.2 | 2.8 | REACTOME PROTEOLYTIC CLEAVAGE OF SNARE COMPLEX PROTEINS | Genes involved in Proteolytic cleavage of SNARE complex proteins |
| 0.2 | 5.2 | REACTOME ACTIVATED TAK1 MEDIATES P38 MAPK ACTIVATION | Genes involved in activated TAK1 mediates p38 MAPK activation |
| 0.2 | 4.4 | REACTOME GAP JUNCTION ASSEMBLY | Genes involved in Gap junction assembly |
| 0.2 | 4.5 | REACTOME CITRIC ACID CYCLE TCA CYCLE | Genes involved in Citric acid cycle (TCA cycle) |
| 0.2 | 2.6 | REACTOME NOREPINEPHRINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Norepinephrine Neurotransmitter Release Cycle |
| 0.2 | 1.7 | REACTOME ACTIVATION OF THE AP1 FAMILY OF TRANSCRIPTION FACTORS | Genes involved in Activation of the AP-1 family of transcription factors |
| 0.2 | 22.6 | REACTOME PEPTIDE CHAIN ELONGATION | Genes involved in Peptide chain elongation |
| 0.2 | 5.4 | REACTOME SMOOTH MUSCLE CONTRACTION | Genes involved in Smooth Muscle Contraction |
| 0.2 | 4.8 | REACTOME ZINC TRANSPORTERS | Genes involved in Zinc transporters |
| 0.2 | 6.6 | REACTOME PREFOLDIN MEDIATED TRANSFER OF SUBSTRATE TO CCT TRIC | Genes involved in Prefoldin mediated transfer of substrate to CCT/TriC |
| 0.2 | 0.5 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
| 0.2 | 3.7 | REACTOME DEPOSITION OF NEW CENPA CONTAINING NUCLEOSOMES AT THE CENTROMERE | Genes involved in Deposition of New CENPA-containing Nucleosomes at the Centromere |
| 0.2 | 0.8 | REACTOME PLATELET CALCIUM HOMEOSTASIS | Genes involved in Platelet calcium homeostasis |
| 0.2 | 3.8 | REACTOME REGULATION OF IFNG SIGNALING | Genes involved in Regulation of IFNG signaling |
| 0.2 | 1.1 | REACTOME TRANSFERRIN ENDOCYTOSIS AND RECYCLING | Genes involved in Transferrin endocytosis and recycling |
| 0.2 | 17.7 | REACTOME RESPONSE TO ELEVATED PLATELET CYTOSOLIC CA2 | Genes involved in Response to elevated platelet cytosolic Ca2+ |
| 0.2 | 1.7 | REACTOME E2F ENABLED INHIBITION OF PRE REPLICATION COMPLEX FORMATION | Genes involved in E2F-enabled inhibition of pre-replication complex formation |
| 0.2 | 1.4 | REACTOME P38MAPK EVENTS | Genes involved in p38MAPK events |
| 0.1 | 2.8 | REACTOME RIP MEDIATED NFKB ACTIVATION VIA DAI | Genes involved in RIP-mediated NFkB activation via DAI |
| 0.1 | 1.4 | REACTOME SIGNALING BY CONSTITUTIVELY ACTIVE EGFR | Genes involved in Signaling by constitutively active EGFR |
| 0.1 | 2.4 | REACTOME AMINO ACID SYNTHESIS AND INTERCONVERSION TRANSAMINATION | Genes involved in Amino acid synthesis and interconversion (transamination) |
| 0.1 | 0.4 | REACTOME BINDING AND ENTRY OF HIV VIRION | Genes involved in Binding and entry of HIV virion |
| 0.1 | 1.3 | REACTOME INHIBITION OF REPLICATION INITIATION OF DAMAGED DNA BY RB1 E2F1 | Genes involved in Inhibition of replication initiation of damaged DNA by RB1/E2F1 |
| 0.1 | 0.3 | REACTOME ACETYLCHOLINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Acetylcholine Neurotransmitter Release Cycle |
| 0.1 | 1.4 | REACTOME CD28 DEPENDENT VAV1 PATHWAY | Genes involved in CD28 dependent Vav1 pathway |
| 0.1 | 1.8 | REACTOME TRANSPORT OF ORGANIC ANIONS | Genes involved in Transport of organic anions |
| 0.1 | 3.7 | REACTOME PERK REGULATED GENE EXPRESSION | Genes involved in PERK regulated gene expression |
| 0.1 | 2.0 | REACTOME CYCLIN A B1 ASSOCIATED EVENTS DURING G2 M TRANSITION | Genes involved in Cyclin A/B1 associated events during G2/M transition |
| 0.1 | 1.4 | REACTOME OPSINS | Genes involved in Opsins |
| 0.1 | 3.1 | REACTOME ABCA TRANSPORTERS IN LIPID HOMEOSTASIS | Genes involved in ABCA transporters in lipid homeostasis |
| 0.1 | 1.9 | REACTOME DOWNSTREAM TCR SIGNALING | Genes involved in Downstream TCR signaling |
| 0.1 | 3.7 | REACTOME SEMA4D INDUCED CELL MIGRATION AND GROWTH CONE COLLAPSE | Genes involved in Sema4D induced cell migration and growth-cone collapse |
| 0.1 | 2.7 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
| 0.1 | 1.4 | REACTOME GLUCURONIDATION | Genes involved in Glucuronidation |
| 0.1 | 3.7 | REACTOME RAP1 SIGNALLING | Genes involved in Rap1 signalling |
| 0.1 | 3.1 | REACTOME SYNTHESIS OF GLYCOSYLPHOSPHATIDYLINOSITOL GPI | Genes involved in Synthesis of glycosylphosphatidylinositol (GPI) |
| 0.1 | 1.8 | REACTOME TANDEM PORE DOMAIN POTASSIUM CHANNELS | Genes involved in Tandem pore domain potassium channels |
| 0.1 | 2.2 | REACTOME ABC FAMILY PROTEINS MEDIATED TRANSPORT | Genes involved in ABC-family proteins mediated transport |
| 0.1 | 2.1 | REACTOME SYNTHESIS OF SUBSTRATES IN N GLYCAN BIOSYTHESIS | Genes involved in Synthesis of substrates in N-glycan biosythesis |
| 0.1 | 2.4 | REACTOME N GLYCAN ANTENNAE ELONGATION | Genes involved in N-Glycan antennae elongation |
| 0.1 | 1.9 | REACTOME PTM GAMMA CARBOXYLATION HYPUSINE FORMATION AND ARYLSULFATASE ACTIVATION | Genes involved in PTM: gamma carboxylation, hypusine formation and arylsulfatase activation |
| 0.1 | 1.6 | REACTOME CTNNB1 PHOSPHORYLATION CASCADE | Genes involved in Beta-catenin phosphorylation cascade |
| 0.1 | 2.1 | REACTOME DCC MEDIATED ATTRACTIVE SIGNALING | Genes involved in DCC mediated attractive signaling |
| 0.1 | 0.6 | REACTOME CDC6 ASSOCIATION WITH THE ORC ORIGIN COMPLEX | Genes involved in CDC6 association with the ORC:origin complex |
| 0.1 | 9.2 | REACTOME RESPIRATORY ELECTRON TRANSPORT ATP SYNTHESIS BY CHEMIOSMOTIC COUPLING AND HEAT PRODUCTION BY UNCOUPLING PROTEINS | Genes involved in Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins. |
| 0.1 | 1.4 | REACTOME SIGNAL TRANSDUCTION BY L1 | Genes involved in Signal transduction by L1 |
| 0.1 | 1.5 | REACTOME GLYCOGEN BREAKDOWN GLYCOGENOLYSIS | Genes involved in Glycogen breakdown (glycogenolysis) |
| 0.1 | 0.5 | REACTOME SIGNALING BY SCF KIT | Genes involved in Signaling by SCF-KIT |
| 0.1 | 0.6 | REACTOME INFLAMMASOMES | Genes involved in Inflammasomes |
| 0.1 | 0.2 | REACTOME SEMA3A PLEXIN REPULSION SIGNALING BY INHIBITING INTEGRIN ADHESION | Genes involved in SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion |
| 0.1 | 0.4 | REACTOME TRAF6 MEDIATED INDUCTION OF TAK1 COMPLEX | Genes involved in TRAF6 mediated induction of TAK1 complex |
| 0.1 | 3.6 | REACTOME INTEGRIN CELL SURFACE INTERACTIONS | Genes involved in Integrin cell surface interactions |
| 0.1 | 1.1 | REACTOME PROCESSIVE SYNTHESIS ON THE LAGGING STRAND | Genes involved in Processive synthesis on the lagging strand |
| 0.1 | 1.7 | REACTOME IL RECEPTOR SHC SIGNALING | Genes involved in Interleukin receptor SHC signaling |
| 0.1 | 15.6 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
| 0.1 | 2.7 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
| 0.1 | 2.3 | REACTOME ENDOSOMAL SORTING COMPLEX REQUIRED FOR TRANSPORT ESCRT | Genes involved in Endosomal Sorting Complex Required For Transport (ESCRT) |
| 0.1 | 0.7 | REACTOME KERATAN SULFATE DEGRADATION | Genes involved in Keratan sulfate degradation |
| 0.1 | 0.8 | REACTOME SIGNALING BY NOTCH3 | Genes involved in Signaling by NOTCH3 |
| 0.1 | 1.4 | REACTOME SIGNALING BY NODAL | Genes involved in Signaling by NODAL |
| 0.1 | 2.4 | REACTOME O LINKED GLYCOSYLATION OF MUCINS | Genes involved in O-linked glycosylation of mucins |
| 0.1 | 2.2 | REACTOME INTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Intrinsic Pathway for Apoptosis |
| 0.1 | 1.7 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
| 0.1 | 1.3 | REACTOME INTERFERON GAMMA SIGNALING | Genes involved in Interferon gamma signaling |
| 0.1 | 1.3 | REACTOME CGMP EFFECTS | Genes involved in cGMP effects |
| 0.1 | 1.1 | REACTOME GENERATION OF SECOND MESSENGER MOLECULES | Genes involved in Generation of second messenger molecules |
| 0.1 | 9.6 | REACTOME PEPTIDE LIGAND BINDING RECEPTORS | Genes involved in Peptide ligand-binding receptors |
| 0.1 | 0.5 | REACTOME FORMATION OF FIBRIN CLOT CLOTTING CASCADE | Genes involved in Formation of Fibrin Clot (Clotting Cascade) |
| 0.1 | 0.4 | REACTOME ACTIVATION OF IRF3 IRF7 MEDIATED BY TBK1 IKK EPSILON | Genes involved in Activation of IRF3/IRF7 mediated by TBK1/IKK epsilon |
| 0.1 | 0.5 | REACTOME CTLA4 INHIBITORY SIGNALING | Genes involved in CTLA4 inhibitory signaling |
| 0.1 | 1.2 | REACTOME DEGRADATION OF THE EXTRACELLULAR MATRIX | Genes involved in Degradation of the extracellular matrix |
| 0.0 | 1.7 | REACTOME PEROXISOMAL LIPID METABOLISM | Genes involved in Peroxisomal lipid metabolism |
| 0.0 | 0.5 | REACTOME SIGNAL ATTENUATION | Genes involved in Signal attenuation |
| 0.0 | 2.2 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
| 0.0 | 1.4 | REACTOME CYTOSOLIC TRNA AMINOACYLATION | Genes involved in Cytosolic tRNA aminoacylation |
| 0.0 | 1.6 | REACTOME SYNTHESIS OF PIPS AT THE PLASMA MEMBRANE | Genes involved in Synthesis of PIPs at the plasma membrane |
| 0.0 | 0.8 | REACTOME ACTIVATED NOTCH1 TRANSMITS SIGNAL TO THE NUCLEUS | Genes involved in Activated NOTCH1 Transmits Signal to the Nucleus |
| 0.0 | 0.4 | REACTOME REGULATION OF INSULIN SECRETION BY GLUCAGON LIKE PEPTIDE1 | Genes involved in Regulation of Insulin Secretion by Glucagon-like Peptide-1 |
| 0.0 | 0.6 | REACTOME BILE SALT AND ORGANIC ANION SLC TRANSPORTERS | Genes involved in Bile salt and organic anion SLC transporters |
| 0.0 | 0.8 | REACTOME P2Y RECEPTORS | Genes involved in P2Y receptors |
| 0.0 | 0.8 | REACTOME REGULATION OF AMPK ACTIVITY VIA LKB1 | Genes involved in Regulation of AMPK activity via LKB1 |
| 0.0 | 3.7 | REACTOME MITOTIC PROMETAPHASE | Genes involved in Mitotic Prometaphase |
| 0.0 | 1.7 | REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
| 0.0 | 0.8 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
| 0.0 | 0.4 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
| 0.0 | 1.6 | REACTOME SIGNALING BY PDGF | Genes involved in Signaling by PDGF |
| 0.0 | 3.3 | REACTOME TRANSCRIPTIONAL REGULATION OF WHITE ADIPOCYTE DIFFERENTIATION | Genes involved in Transcriptional Regulation of White Adipocyte Differentiation |
| 0.0 | 0.3 | REACTOME POST TRANSLATIONAL MODIFICATION SYNTHESIS OF GPI ANCHORED PROTEINS | Genes involved in Post-translational modification: synthesis of GPI-anchored proteins |
| 0.0 | 0.3 | REACTOME ENDOGENOUS STEROLS | Genes involved in Endogenous sterols |
| 0.0 | 0.9 | REACTOME SRP DEPENDENT COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE | Genes involved in SRP-dependent cotranslational protein targeting to membrane |
| 0.0 | 0.4 | REACTOME G2 M CHECKPOINTS | Genes involved in G2/M Checkpoints |
| 0.0 | 0.7 | REACTOME SIGNALING BY FGFR1 FUSION MUTANTS | Genes involved in Signaling by FGFR1 fusion mutants |
| 0.0 | 0.4 | REACTOME UNWINDING OF DNA | Genes involved in Unwinding of DNA |
| 0.0 | 0.4 | REACTOME OXYGEN DEPENDENT PROLINE HYDROXYLATION OF HYPOXIA INDUCIBLE FACTOR ALPHA | Genes involved in Oxygen-dependent Proline Hydroxylation of Hypoxia-inducible Factor Alpha |
| 0.0 | 0.3 | REACTOME CALNEXIN CALRETICULIN CYCLE | Genes involved in Calnexin/calreticulin cycle |
| 0.0 | 0.5 | REACTOME NETRIN1 SIGNALING | Genes involved in Netrin-1 signaling |
| 0.0 | 0.2 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
| 0.0 | 0.2 | REACTOME FORMATION OF INCISION COMPLEX IN GG NER | Genes involved in Formation of incision complex in GG-NER |